<!DOCTYPE html>
<html style="overflow: hidden;">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320?np=y">
<meta name="wpd_url" content="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320?np=y">
<meta name="wpd_date" content="2013-04-21T09:35Z">
<script async="async" type="text/javascript">s_c_il[1].cdw=s_c_il[1].d.write;s_c_il[1].cdwb="";s_c_il[1].d.write=function(m){s_c_il[1].cdwb+=m};
s.channel="publications";
s.pageName="article";
if (typeof (SDM) != 'undefined') {
  if (typeof(SDM.pageType) != 'undefined' &&
      typeof(SDM.issn_or_isbn) != 'undefined' &&
      typeof(SDM.pm) != 'undefined' &&
      typeof(SDM.pm.pii) != 'undefined' &&
      typeof(SDM.pm.contentType) != 'undefined') {
      var ct=SDM.pm.contentType.toLowerCase();
      if (ct=="jl") {
        s.prop1="journal";
      } else if (ct=="bk") {
         s.prop1="book";
      } else if (ct=="rw") {
          s.prop1="refwork";
      } else if (ct=="bs") {
          s.prop1="bookseries";
      } else if (ct=="hb") {
           s.prop1="handbook";
      }
      s.eVar17=SDM.pageType.toLowerCase();
      s.eVar14=SDM.issn_or_isbn; 
      s.eVar28=SDM.issn_or_isbn;
      s.products=";"+SDM.pm.pii;
    }
}
s.events="prodView,event5";
s.prop2=s.prop1;
s.prop4="article";
s_c_il[1].d.write=s_c_il[1].cdw;s_c_il[1].crl(0,1)</script><script src="sciencedirect.js" async="async" type="text/javascript"></script>
<script src="204774041.js"></script>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<script> var ts1 = new Date().getTime(); </script>
<!-- static const char articletmpl_sccsId[] = "%W%  %G% %U%  Retrieved: %H% %T%"; -->
<meta name="robots" content="NOARCHIVE">
<meta name="robots" content="noodp">
<meta name="robots" content="noydir">
<link rel="canonical" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320">


<link rel="shortcut icon" href="faviconSD.ico" type="image/x-icon">
<title>

ScienceDirect.com - 

    
        
    
    Current Opinion in Virology
 - Are subtype differences important in HIV drug resistance?</title>






<script>

if( typeof(ts1) == "undefined" ){ ts1= new Date().getTime(); }
Array.prototype.rt = function(label,ts){this.push( "{lbl:"+label+",ts:"+(ts||ts==0?ts:new Date().getTime())+"}" );}
var prs = [];
prs.rt( "head", ts1 );
function loadPDF(){}
</script>


<!--[if lte IE 7]>
<script src="http://cdn.els-cdn.com/sd/js/json2_131R4.js.min"></script>
<![endif]-->

<link rel="stylesheet" type="text/css" href="S1879625712001320.css" media="all">
</head>
<body style="overflow: hidden;">


<script>prs.rt('body_start');</script>
<script>

var refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S1879625712001320";
var updatedCitedBy = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_updateCitedBy=";
var refResolvePath = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_eid=1-s2.0-S1879625712001320&_refCnt=61&_docType=article";

// these variables handle the reference resolution. Please ignore the naming.
// the first variable myMap will hold an associative array of links by bibID
// the second variable myXabsCounts holds the scopus counts.
var myMap = []; // html of links for references.
var myXabsCounts = []; // scopus counts
</script>
<div style="width: 1606px; left: 62px; display: block;" class="js" id="header-area">
  <div id="header" class="outerWrapper">
<div style="background-color: rgb(255, 255, 255); position: relative;" class="outerWrapper">
<div id="masthead">

<!-- INSERTS THE TEMPLATE VARIABLES POPULATED FROM DB for SCIVERSE and PRODUCT labels -->

<div class="logoSciVerseBlk"> <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" <span="" class="logoSciVerseImg">&nbsp;</a> </div> <div class="logoScienceDirectBlk"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" title="ScienceDirect -The world's leading full-text scientific database"><span class="logoScienceDirectImg">&nbsp;</span></a></div>

</div>
<div id="suites" class="clearfix" aria-label="SciVerse" role="navigation">
<ul class="suites"><li><a href="http://www.hub.sciverse.com/action/home" title="Hub - SciVerse's integrated search">Hub</a></li><li><a title="ScienceDirect - the world's leading full-text scientific database" class="selected">ScienceDirect</a></li><li><a href="http://www.scopus.com.libgate.library.nuigalway.ie/" title="Scopus - the largest abstract and citation database of research literature and quality web sources">Scopus</a></li><li><a href="http://www.applications.sciverse.com/action/userhome" title=" Applications - SciVerse Applications" class="last">Applications</a></li></ul>
</div>
</div>		

     <!-- if not logged in -->
	   

			

    <div id="login" class="clearfix">
    	<ul>
		<li>
    
      <a href="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science?_ob=RegistrationURL&amp;_method=display&amp;_type=ip&amp;_returnURL=http%3A%2F%2Fwww.sciencedirect.com%2Fsciencenp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=a003226ccf19a695734972d3bd54db42" target="_top" title="Register a ScienceDirect username and password for using alerts and other personal features">Register</a>
    
  </li>
  <!--top right widget-->
  <li class="login " id="loginPlus"><a href="javascript:LoginBox.flipLogin('loginBox',null);" title="Login to ScienceDirect" class="novisit plus nojs" id="loginPlusScript">Login</a><noscript><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HomePageURL&_method=userHomePage&_fl=y&_acct=C000007922&_version=1&_urlVersion=0&_userid=103680&md5=0773bdb54cea8075a9f1176d3dba54dc" title="Open the Login Box" class="plus" id="loginPlusNoScript" >Login</a></noscript>
  </li>
           
           <li class="last"><a href="http://www.scival.com/" title="Go to SciVal Suite">Go to SciVal Suite</a></li> 
        </ul>
    </div>
    
	<div id="loginBox" style="width: 600px; display: none;">
		
        <div style="width: 285px; float: right; border-left: 1px solid rgb(155, 155, 155); padding-left: 10px; min-height: 180px;">
        
        <div class="sampletext">
        <div style="font-weight: bold; padding-bottom: 5px;">Login via your institution</div>
		
		
		<div><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=FederationURL&amp;_method=display&amp;_type=f&amp;prevURL=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1879625712001320%3Fnp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=f3508a614debf1e80eb4d8a0d8308a63" title="Go to Athens/ Institution login">Athens / Institution login</a></div>
		
        </div>
	
				
		
                  
                
            
            
        </div>
		
        <div class="padding" style="width: 285px;">
            <form name="sdLogin" method="POST" action="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science/login" id="login-box-form" style="margin: 0px;">
            <b><span style="text-align: right; font-weight: bold;">Login using your SciVerse credentials</span></b>
			<input name="login" value="login" type="hidden">
            <div style="margin-top: 20px;">
            <label for="username"><span style="text-align: right;">Username:</span>
            <input id="username" name="userid" title="Please enter your username here" type="text"></label>
            </div>
            
            <div style="margin-top: 7px;">
            <label for="password"><span style="text-align: right;">Password:</span>
            <input id="password" name="password" maxlength="20" title="Please enter your password here" onkeypress="if(13==event.keyCode)this.form.submit();if (13==event.keyCode)return false;" type="password"></label>
            </div>
                   
                       
			
			<div class="remember">
			<input checked="" name="rememberid" id="rememberMe" value="Y" class="allCheck top2fix" title="Checking this option will log you in automatically next time you visit ScienceDirect" type="checkbox">
			<label for="rememberMe" title="Checking this option will log you in automatically next time you visit ScienceDirect">Remember me</label>
			</div>
            
			<input name="_ob" value="MiamiLogonURL" type="hidden">
			<input name="targetURL" value="http://www.sciencedirect.com/science/article/pii/S1879625712001320?np=y" type="hidden">
			<input name="returnURL" value="http://www.sciencedirect.com/science/article/pii/S1879625712001320?np=y" type="hidden">
            <div class="submit">
			
			<div style="float: left; padding-left: 0px;"><input class="button" name="arrow" alt="Login to ScienceDirect" title="Login to ScienceDirect" value="Login" type="Submit"></div>
        
			
			<div class="notRegistered"><span class="astPad">| </span><span><a href="https://www-sciencedirect-com.libgate.library.nuigalway.ie/science?_ob=RegistrationURL&amp;_method=display&amp;_type=ip&amp;_returnURL=http%3A%2F%2Fwww.sciencedirect.com%2Fsciencenp%3Dy&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=a003226ccf19a695734972d3bd54db42" title="" target="_top">Not Registered?</a></span></div>
			
			
			<div style="clear: left;"></div>
            </div>
			
            <div class="forgotpass">
			<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=ReminderURL&amp;_method=display&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=d42879e2c3ee578ec4edb1badc8cf513" target="passwd" onclick="var remindWin;remindWin=window.open('','passwd','scrollbars=yes,resizable=yes,directories=no,toolbar=n,menubar=no,status=no,width=650,height=300');" title="Click here for help in recovering your ScienceDirect access">Forgotten username or password?</a>
            </div>
            </form>
        </div>
	</div>

	<!-- logged in -->
	     



<div id="navigationTop" class="clearfix" aria-label="ScienceDirect" role="navigation">
    <ul class="nav main">
        <li class="last">
            <a class=" canonHomeLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/" method="userHomePage" btn="Y" zone="TopNavBar" origin="home" target="_top" name="Home" title="Home">Home</a>
        </li>
        <li>
            <!--<h1>-->
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/browse" type="all" auth="y" zone="TopNavBar" origin="article" target="_top" name="Publications" title="Publications">Publications</a>
            <!--</h1>-->
        </li>
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSearchURL&amp;_method=requestForm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=6f00b17e70582bccfd79c0043e2d7e9d" target="_top" name="Search" title="Search">Search</a>
        </li>
        
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=UserSubscriptionURL&amp;_method=begin&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=8246689b76c81456079cab859fc0613c" target="_top" name="account" title="My settings">My settings</a>
        </li>
        
        
        
        <li>
            <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSDIURL&amp;_method=listAlerts&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=7614e1367f59f6ad24497b7cb1295fc7" target="_top" name="alert" title="Alerts">My alerts</a>
        </li>
        
        
    </ul>
    <ul class="nav misc">
        <li><span id="ChatHeader"></span></li>          
        <li class="last" style="margin-right: 247px;"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HelpURL&amp;_file=browse_open_doc.htm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=3078a5cf677d428f5de42e4c8b948657" target="sdhelp" title="Help (Opens new window)" onclick="var helpWin; helpWin=window.open('http://www.sciencedirect.com/science?_ob=HelpURL&amp;_file=browse_open_doc.htm&amp;_btn=Y&amp;_zone=TopNavBar&amp;_origin=article&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=3078a5cf677d428f5de42e4c8b948657','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570'); helpWin.focus(); return false">Help</a></li>      
    </ul> 
    
                
        <div id="bannerTop">                
            <div>Brought to you by:<br>
            
                <a href="http://www.library.nuigalway.ie.libgate.library.nuigalway.ie/" onclick="openNS('http://www.library.nuigalway.ie'); return false;">James Hardiman Library</a>
            
            </div>
        </div>
        
               
</div>

</div>


</div>













<div style="top: 102px; width: 1606px; left: 62px; bottom: 0px; border-top: medium none;" class="js" id="page-area">
  <div style="width: 1606px;" class="js" id="articleToolbar">
    <div id="articleNav">
  <ul aria-label="Article options" role="navigation">
    <li>
      <!-- return to gateway -->
       
      
    </li>





<li>
      <div class="icon_exportarticlesci_dir" title="Export citation">
        <div class="icon"></div>
        <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=DownloadURL&amp;_method=confirm&amp;_eidkey=1-s2.0-S1879625712001320&amp;count=1&amp;_docType=FLA&amp;zone=toolbar&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=acb8d3c8f4fda20cd3b6f3d780b1595b">Export citation</a>
      </div>
</li>
  




<li>
  <div class="icon_pdf">
    <div class="icon"></div>
    <a id="pdfLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiImageURL&amp;_cid=270558&amp;_user=103680&amp;_pii=S1879625712001320&amp;_check=y&amp;_origin=article&amp;_zone=toolbar&amp;_coverDate=2012-Oct-31&amp;view=c&amp;originContentFamily=serial&amp;wchp=dGLbVlk-zSkWb&amp;md5=f6c1cf8cff694afc3207ceaa10717157&amp;pid=1-s2.0-S1879625712001320-main.pdf" target="newPdfWin" pdfurl="http://www.sciencedirect.com/science?_ob=MiamiImageURL&amp;_cid=270558&amp;_user=103680&amp;_pii=S1879625712001320&amp;_check=y&amp;_origin=article&amp;_zone=toolbar&amp;_coverDate=2012-Oct-31&amp;view=c&amp;originContentFamily=serial&amp;wchp=dGLbVlk-zSkWb&amp;md5=f6c1cf8cff694afc3207ceaa10717157&amp;pid=1-s2.0-S1879625712001320-main.pdf" class="big pdf ext_sdlink" style="cursor: pointer;" title="Download PDF">PDF  (424 K)</a>
  </div>
</li>
 
 



<li class="optionsPos">
      <div id="moreOptionsButton" title="Show article options">
        <a href="#">More options...</a>
        <div class="down_sci_dir"></div>
      </div>

<!-- More Options Starts-->
<div id="moreOptionsMenu" class="articleOptions articleOptionssci_dir">
<ul class="menuContent">


    
    <li>
    <ul class="ereader">
        <li class="title">

            eReader format &nbsp;<a title="Help" onclick="var help; help=window.open('http://www.sciencedirect.com/science/help');">What's this?</a>
        </li>
        <li>
            <a id="epubLink" class="erLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320?np=y" title="ePub">
                <span class="icon epub">&nbsp;</span><span class="ereadertext">ePub</span>
            </a>
        </li>
        <li>
            <a id="mobiLink" class="erLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320?np=y" title="Mobipocket">
                <span class="icon mobi">&nbsp;</span><span class="ereadertext">Mobipocket</span>
            </a>
        </li>
    </ul>
    </li>
    





<li>
    <div class="emailsci_dir">
        <div></div>
        <a title="Email this article" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=EmailFriendURL&amp;_method=gatherInfo&amp;refSource=html&amp;count=1&amp;_eidkey=1-s2.0-S1879625712001320&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=59b196af3a3c9841e40062adaabc25bf">Email article</a>
    </div>
</li>

  




   
       <li>
          <div id="alertOn" style="display: none;" class="alertsci_dir">
            <div></div>
            <span>

            Signed up for journal alerts&nbsp;[<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=PublicationURL&amp;newIssueAlert=2&amp;_cid=270558&amp;_pubType=J&amp;_auth=y&amp;originContentFamily=serial&amp;_pii=S1879625712001320&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=bcb86bb106c52b55a097c12ce9263a0a">remove</a>]</span>
          </div>
          <div id="alertOff" style="display: inline;" class="alertsci_dir">
            <div></div>
            <a title="Set new Volumes / Issues alert" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=PublicationURL&amp;newIssueAlert=2&amp;_cid=270558&amp;_pubType=J&amp;_auth=y&amp;originContentFamily=serial&amp;_pii=S1879625712001320&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=bcb86bb106c52b55a097c12ce9263a0a">

            Alert me about new articles in this journal
            </a>
          </div>
          <div id="rsltInd" style="display: none;">
            <div class="imgIcon"><h3><img src="errorIcon.gif" alt="Failure" title="Failure"></h3></div>
            <div class="confirmMsgText">Your selection(s) could not be saved due to an internal error. Please try again.</div>
          </div>          
      </li>
    


<li>
    <div class="thumbnailsci_dir">
        <div></div>
        <a href="javascript:void(0);" id="optImgToggle" title="">Show thumbnail images</a>
    </div>
</li>

</ul>
<div id="articleOptionsAd" role="banner" class="ad"></div>
</div>
<!-- More options Ends -->
</li>
<li id="erToolbar"></li>




</ul>
</div>

<div class="sdSearch" aria-label="Quick search" role="search">
    <fieldset>
        <div class="left">
            <input style="color: rgb(155, 155, 155);" id="quickSearch" name="quickSearch" value="Search ScienceDirect" size="30" maxlength="450" title="Perform a quick search on ScienceDirect" type="text"><button class="submit" title="Submit quick search">Search</button>
        </div>
        <div id="quickSearchButton" class="right" title="Show more quick search options">
            <div class="down_sci_dir"></div>
        </div>
    </fieldset>
</div>
<div class="clear"></div>
<div style="width: 1579px;" class="quickSearch" id="sdQuickSearch" aria-label="Extended search" role="search">
<div class="extSearch" role="search" aria-label="Quick Search">


<form name="qkSrch" method="get" target="_top" action="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science" style="margin: 0px;">
<input name="_ob" value="QuickSearchURL" type="hidden">
<input name="_method" value="submitForm" type="hidden">
<input name="_acct" value="C000007922" type="hidden">
<input name="_origin" value="article" type="hidden">
<input name="_zone" value="qSearch" type="hidden">
<input name="md5" value="150d94845014a5f578fff24e6f5ff0a9" type="hidden">

<table style="margin: 0px;" border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr valign="middle">

<!-- JS enabled. Code for Articles -->

<td align="center" nowrap="nowrap">
<label for="Articles" style="cursor: pointer; padding-right: 0px; margin-left: 2px;" class="nojs">Articles</label>
<input class="qsRadio nojs" name="searchtype" id="Articles" value="a" checked="checked" style="" type="radio">
<noscript>

<!-- JS disabled. Code for Articles -->
<span style="margin-left:13px;">Articles</span>
</noscript>
</td>


<!-- Code related for toggling labels -->


<td align="right"><label for="qs_all" id="fieldLabel">&nbsp;&nbsp;&nbsp;&nbsp;All fields</label></td>
<td align="left"><input class="textbox qsinput xpstyle qsImgBlurFocus" name="qs_all" id="qs_all" value="" size="30" maxlength="450" title="For example: heart attack AND behavior?" type="text"></td>




<td align="right"><label for="qs_author">&nbsp;&nbsp;&nbsp;&nbsp;Author</label></td>
<td colspan="5" align="left"><input class="textbox qsinput xpstyle" name="qs_author" id="qs_author" value="" size="33" maxlength="450" title="e.g. J S Smith or John Smith or Smith JS" style="_width:100%" type="text"></td>
<td nowrap="nowrap">

</td><td></td><td></td>
<td align="right" nowrap="nowrap" valign="middle" width="90%">
<a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiSearchURL&amp;_method=requestForm&amp;_btn=Y&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=1&amp;_userid=103680&amp;md5=36be44d02ea7cffa13df23aca528620a" style="vertical-align: bottom; font-size: 0.92em;">Advanced search</a>
</td>
</tr>
<tr>

<!-- JS enabled. Code for images -->

<td align="center" nowrap="nowrap">
<label for="Images" style="cursor: pointer; padding-right: 0px;" class="nojs">Images</label>
<input class="qsRadio nojs" name="searchtype" id="Images" value="i" type="radio">
<noscript>

<!-- JS disabled. Code for Images -->
<span style="margin-left:13px;"><a href="/science?np=y&imgSel=Y" >Images</a></span>
</noscript>
</td>


<td align="right"><label for="qs_title">&nbsp;&nbsp;&nbsp;&nbsp;Journal/Book&nbsp;title</label></td>
<td align="left"><input autocomplete="off" class="textbox qsinput xpstyle ui-autocomplete-input" id="qs_title" name="qs_title" value="" size="30" maxlength="450" title="For example: journal of molecular biology" type="text"><span class="ui-helper-hidden-accessible" aria-live="polite" role="status"></span></td>


<td class="toggleQukSrch2" align="right"><label for="qs_vol" id="volField">&nbsp;&nbsp;&nbsp;&nbsp;Volume</label></td>
<td class="toggleQukSrch" align="left"><input class="textbox qsinput xpstyle" name="qs_vol" id="qs_vol" value="" size="3" maxlength="10" style="width: 30px;" type="text"></td>
<td class="toggleQukSrch2" align="right"><label for="qs_issue" id="issueField">&nbsp;&nbsp;Issue</label></td>
<td class="toggleQukSrch" align="left"><input class="textbox qsinput xpstyle" name="qs_issue" id="qs_issue" value="" size="3" maxlength="10" style="width: 30px;" type="text"></td>
<td class="toggleQukSrch2" align="right"><label for="qs_pages" id="pageField">&nbsp;&nbsp;Page</label></td>
<td class="toggleQukSrch" align="right"><input class="textbox qsinput xpstyle" name="qs_pages" id="qs_pages" value="" size="3" maxlength="10" title="For example: 14-27" style="width: 30px;" type="text"></td>


<td align="right" nowrap="nowrap">
<input class="button" id="submit_search" alt="Submit Quick Search" title="Submit Quick Search" value="Search" name="sdSearch" type="Submit">
</td> 
<td colspan="8" align="right" nowrap="nowrap" valign="bottom">
<a class="icon_qmarkHelpsci_dir" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=HelpURL&amp;_origin=srch_form&amp;_zone=TopNavBar&amp;_file=qs_tips.htm&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=ae1e488939a34c669c24f09774e72b25" target="sdhelp" onmouseover="window.status='Help is Available';return true" onmouseout="window.status='';return true" onclick="var helpWin;helpWin=window.open('http://www.sciencedirect.com/science?_ob=HelpURL&amp;_file=qs_tips.htm&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=426a1ddabd0771203259aa91ecaa495c','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570');helpWin.focus();return false" style="font-size: 0.92em; padding-right: 0px;">Search tips</a>
</td>
</tr>
</tbody></table>
</form>
</div>



 
</div>

<div style="color: rgb(255, 0, 0); font-weight: bold; border: 0px solid red;">
  
  
  
  
</div>





  </div>
  <div style="clear: both;"></div>
  <div style="margin-top: 26px; left: 3px;" class="js" id="leftCloseBar">
      <div class="closed" title="Open to view article outline"></div>
  </div>
  <div style="top: 26px; left: 3px; width: 258px; height: 246px;" id="leftPane" class="column js" aria-label="table of contents" role="navigation">
  <div class="js" id="leftPaneInner"><div id="olGraphCbBox"><label><input id="outlineGraphicsCheckBox" checked="true" type="checkBox">Show thumbnails in outline</label></div>
    <div data-st="0" style="top: 32px; overflow: hidden; background: none repeat ; 0% rgb(236, 242, 246);" id="outline" class="outline js">
      <script type="text/javascript">

      document.write("<div class='outlineMsg'>Article outline is loading...</div>");
      </script>
      <noscript>

      <div class="infoMsg">
      <div style="float: left; width: 20px; "><img border="0" src="http://cdn.els-cdn.com/sd/alertIcon.gif" valign="top" alt="Alert message"></div>
      <div style="padding-left:25px;">JavaScript is disabled on your browser. 
<div style="padding-top:10px;">
      Please enable JavaScript to use all the features on this page.</div></div>
      </div>
      </noscript>
      <ul style="display: block; background: none repeat ; 0% rgb(236, 242, 246);" id="itemOutline"><li class="outlineFocus outlineFocusFirst outlineFocusLast" style="margin-right: 15px;"><div id="ol_secGabs_1" class="io item h3sec"><a class="tocLink" href="#secGabs_1" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Highlights<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0005" class="io item h2sec"><a class="tocLink" href="#sec0005" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Introduction<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0010" class="io item h2sec"><a class="tocLink" href="#sec0010" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">HIV-1 origin, subtypes and recombinants<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0015" class="io item h2sec"><a class="tocLink" href="#sec0015" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Subtyping tools and drug resistance databases<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_fig0005" class="io item h2sec fig"><a class="tocLink" href="#fig0005" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');"><img data-loaded="true" src="1-s2.0-S1879625712001320-gr1.sml" class="smlImgLazyJSB greyImg displayImg" data-smlsrc="http://ars.els-cdn.com/content/image/1-s2.0-S1879625712001320-gr1.sml" data-thumbheight="164"></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_tbl0005" class="io item h2sec tbl"><div class="olIcon olIconTbl"></div><a class="tocLink olIcon olIconTbl" href="#tbl0005" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial'); ">Table 1</a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0020" class="io item h2sec"><a class="tocLink" href="#sec0020" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Nucleoside and nucleotide reverse transcriptase inhibitors<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0025" class="io item h2sec"><a class="tocLink" href="#sec0025" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Non-nucleoside reverse transcriptase inhibitors<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0030" class="io item h2sec"><a class="tocLink" href="#sec0030" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Protease inhibitors<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0035" class="io item h2sec"><a class="tocLink" href="#sec0035" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Integrase inhibitors<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0040" class="io item h2sec"><a class="tocLink" href="#sec0040" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Clinical efficacy of new antiretroviral agents by HIV-1 subtype<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_tbl0010" class="io item h2sec tbl"><div class="olIcon olIconTbl"></div><a class="tocLink olIcon olIconTbl" href="#tbl0010" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial'); ">Table 2</a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0045" class="io item h2sec"><a class="tocLink" href="#sec0045" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Conclusions<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_sec0050" class="io item h2sec"><a class="tocLink" href="#sec0050" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">References and recommended reading<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_ack001" class="io item h2sec"><a class="tocLink" href="#ack001" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">Acknowledgements<br></a></div></li><li class="" style="margin-right: 15px;"><div id="ol_bibl00bibl0005" class="io item h2sec"><a class="tocLink" href="#bibl00bibl0005" onclick="SD_UTIL.sendUserKeyEvent('displayTOCSection', 'article', 'leftPane', 'serial');">References<br></a></div></li></ul><div style="width: 241px; background: none repeat ; 0% rgb(236, 242, 246);" id="articleLeftAd"></div></div>
      <div id="leftOpenBar">
        <div class="open" title="Open to view article outline"></div>
      </div>
  </div>
  </div>
  <div tabindex="-1" data-st="0" data-dir="u" style="top: 26px; left: 261px;" id="centerPane" class="column js">
    <div id="centerInner" class="centerInner svBigBox js" aria-label="Article" role="main">
      
<script>prs.rt('data_start');</script>
      <div class="authClaim"></div><div class="head"><div class="publisherLogo"><img data-loaded="true" style="display: inline;" alt="" id="pubLogo" class="imgLazyJSB" src="elsevier.gif" data-defaultlogo="/elsevier.gif"><noscript><img alt="" src="http://origin-cdn.els-cdn.com/sd/elsevier.gif"></noscript></div><div class="publicationHead"><div class="title"><a title="Go to Current Opinion in Virology on SciVerse ScienceDirect" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/18796257" querystr="?zone=centerPane" class="cLink"><span>Current Opinion in Virology</span></a></div><p class="volIssue"><a title="Go to table of contents for this volume/issue" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/18796257/2/5">Volume 2, Issue 5</a>, October 2012, Pages 636–643</p><p class="specIssueTitle">Virus evolution / Antivirals and resistance</p></div><div class="publicationCover"><a querystr="?zone=publicationLogo" class="cLink" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/journal/18796257/2/5"><img data-loaded="true" style="display: inline;" alt="Cover image" src="1-s2.0-S1879625712X00063-cov150h.gif" class="toprightlogo imgLazyJSB" data-publogo="1-s2.0-S1879625712X00063-cov150h.gif"><noscript><img alt="Cover image" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S1879625712X00063-cov150h.gif" class="toprightlogo"></noscript></a></div></div><div class="module_topic_paths"></div><h1 class="svTitle" id="">Are subtype differences important in HIV drug resistance?</h1><ul class="authorGroup noCollab" id=""><li><a href="#" class="authorName" id="authname_N5e561cc8N5dc2a940" data-t="a" data-fn="RJ" data-ln="Lessells" data-pos="1">RJ Lessells</a><a title="Affiliation: 1" href="#aff0005" class="intra_ref auth_aff" id="baff0005"><sup>1</sup></a><sup>, </sup><a title="Affiliation: 2" href="#aff0010" class="intra_ref auth_aff" id="baff0010"><sup>2</sup></a>, </li><li><a href="#" class="authorName" id="authname_N5e561cc8N5dc2a9d0" data-t="a" data-fn="DK" data-ln="Katzenstein" data-pos="2">DK Katzenstein</a><a title="Affiliation: 3" href="#aff0015" class="intra_ref auth_aff" id="baff0015"><sup>3</sup></a>, </li><li><a href="#" class="authorName" id="authname_N5e561cc8N5dc2aa60" data-t="a" data-fn="T" data-ln="de Oliveira" data-pos="3">T de Oliveira</a><a title="Affiliation: 1" href="#aff0005" class="intra_ref auth_aff" id="baff0005"><sup>1</sup></a><sup>, </sup><a title="Affiliation: 4" href="#aff0020" class="intra_ref auth_aff" id="baff0020"><sup>4</sup></a><sup>, </sup><a href="mailto:tdeoliveira@africacentre.ac.za"><img data-loaded="true" style="display: inline;" class="imgLazyJSB" src="REemail.gif" alt="E-mail the corresponding author" data-inlimg="/entities/REemail.gif"><noscript><img src="http://origin-cdn.els-cdn.com/sd/entities/REemail.gif" alt="E-mail the corresponding author"></noscript></a></li></ul><div class="endLine"></div><ul class="affiliation"><li id="aff0005"><sup>1</sup> <span id="">Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa</span></li><li id="aff0010"><sup>2</sup> <span id="">Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom</span></li><li id="aff0015"><sup>3</sup> <span id="">Stanford University Medical Center, Department of Medicine, Stanford, CA 94305, USA</span></li><li id="aff0020"><sup>4</sup> <span id="">Research Department of Infection, University College of London, London, W1T 4JF, United Kingdom</span></li></ul><!--VALIDHTML--><dl class="articleDates"><dd>Available online 21 September 2012</dd></dl><!--VALIDHTML--><ul class="articleDoi"><li><a id="ddDoi" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.coviro.2012.08.006" target="doilink" onclick="var doiWin; doiWin=window.open('http://dx.doi.org/10.1016/j.coviro.2012.08.006','doilink','scrollbars=yes,resizable=yes,directories=yes,toolbar=yes,menubar=yes,status=yes'); doiWin.focus()">http://dx.doi.org/10.1016/j.coviro.2012.08.006</a>, <a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/help/doi.htm" target="sdhelp" onmouseover="window.status='Help is Available';return true" onclick="var helpWin; helpWin=window.open('http://www.sciencedirect.com/science/help/doi.htm','sdhelp','scrollbars=yes,resizable=yes,directories=no,toolbar=no,menubar=no,status=no,width=760,height=570'); helpWin.focus()">How to Cite or Link Using DOI</a></li></ul><!--VALIDHTML--><ul class="articleInfo"><li class="permissions" id="permissions"><div class="boxLink"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=outwardLink&amp;_partnerName=936&amp;_eid=1-s2.0-S1879625712001320&amp;_pii=S1879625712001320&amp;_origin=article&amp;_zone=art_page&amp;_targetURL=https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3FpublisherName%3DELS%26contentID%3DS1879625712001320%26orderBeanReset%3Dtrue&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=2aeecd4e1615edc7b5e50df625ea7df9" rel="nofollow" class="olSpawnWindow" target="outwardLink">Permissions &amp; Reprints</a></div></li></ul><!--VALIDHTML--><div id="ppvPlaceHolder" class="hidden"></div><!--VALIDHTML--><div id="refersToAndreferredToBy"><dl id="referredToBy" class="documentThread"><!--Referred To By--></dl></div><!--VALIDHTML--><hr id="author1"><div class="abstract svAbstract "><p id="spar0010">The diversity of human immunodeficiency virus type 1 (HIV-1) has given rise to multiple subtypes and recombinant strains. The majority of research into antiretroviral agents and drug resistance has been performed on subtype B viruses, yet non-subtype B strains are responsible for 90% of global infections. Although it seems that combination antiretroviral regimens are effective against all HIV-1 subtypes, there is emerging evidence of subtype differences in drug resistance, relevant to antiretroviral strategies in different parts of the world. For this purpose, extensive sampling of HIV genetic diversity, curation and analyses are required to inform antiretroviral strategies in different parts of the world.</p></div><!--VALIDHTML--><hr id="absgraphical1"><div class="abstract svAbstract"><h4 id="secGabs_1">Highlights</h4><div id="spar0005"><p>► HIV-1 diversity has given rise to numerous subtypes and recombinant forms. ► New subtyping tools can accurately identify the most important HIV-1 variants. ► Public drug resistance databases are useful resources to trace the evolution of drug resistance in different subtypes. ► HIV-1 subtype genetic variation can influence the development of drug resistance and the susceptibility to certain antiretroviral drugs. ► Appreciation of subtype differences is important in the development of new drugs and in the formulation of antiretroviral strategies.</p></div></div><!--VALIDHTML--><script>prs.rt("abs_end");</script><div id="SD_BA1P" class="sgfNoTitleBar sgfNoGadgetBorder svDoNotLink"></div><!--VALIDHTML--><p class="svArticle section" id="par0910"></p><div class="textboxdefault" id="tb0015"><div id="tde"><div class="textboxBody"><p class="svArticle section" id="par0850"><strong class="boldFont">Current Opinion in Virology</strong> 2012, <strong class="boldFont">2</strong>:636–643</p><p class="svArticle section" id="par0935">This review comes from a themed issue on <strong class="boldFont">Antivirals and resistance</strong></p><p class="svArticle section" id="par0945">Edited by <strong class="boldFont">Daniel Lamarre</strong> and <strong class="boldFont">Mark A Wainberg</strong></p><p class="svArticle section" id="par0920">For a complete overview see the <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.sciencedirect.com%252Fscience%252Fjournal%252F18796257%252F2%252F5" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()"><span class="underline">Issue</span></a></span> and the <span class="interref" data-locatortype="doi"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=doi&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fdx.doi.org%252F10.1016%252Fj.coviro.2012.09.002" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()"><span class="underline">Editorial</span></a></span></p><p class="svArticle section" id="par0940">Available online 21st September 2012</p><p class="svArticle section" id="par0225">1879-6257/$ – see front matter, © 2012 Elsevier B.V. All rights reserved.</p><p class="svArticle section" id="par0980"><span class="interref" data-locatortype="doi"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=doi&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fdx.doi.org%252F10.1016%252Fj.coviro.2012.08.006" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()"><strong class="boldFont">http://dx.doi.org/10.1016/j.coviro.2012.08.006</strong></a></span></p></div></div></div><!--VALIDHTML--><p></p><!--VALIDHTML--><h2 class="svArticle" id="sec0005">Introduction</h2><p class="svArticle section" id="par0035">The past decade has seen substantial global scale-up of antiretroviral therapy (ART) for HIV infection and more than six million people are receiving ART in low-income and middle-income countries [<span id="bbib0005"><a href="#bib0005" id="ancbbib0005" class="intra_ref">1</a></span>]. Antiretroviral drug resistance is one of the main threats to global control of HIV [<span id="bbib0010"><a href="#bib0010" id="ancbbib0010" class="intra_ref">2</a></span>]. The majority of persons living with HIV infection are infected with non-subtype B variants of HIV type 1 (HIV-1) [<span id="bbib0015"><a href="#bib0015" id="ancbbib0015" class="intra_ref">3</a></span>]. There is increasing evidence that polymorphisms that occur naturally in different HIV-1 subtypes impact on drug resistance and susceptibility to antiretroviral drugs.</p><!--VALIDHTML--><p class="svArticle section" id="par0040">Here, we outline the latest developments in subtyping tools, drug resistance databases and review recent evidence from <em>in vitro</em> and clinical studies regarding drug resistance among HIV-1 subtypes (<span id="btb0010"><a href="#tb0010" id="ancbtb0010" class="intra_ref">Box 1</a></span>).</p><!--VALIDHTML--><div class="textboxdefault" id="tb0010"><div id="tde"><div class="textboxCaption"><span class="textboxHead">Box 1.&nbsp;</span><span class="caption">Summary of main concepts</span></div><div class="textboxBody"><p class="svArticle section" id="par0160"></p><dl class="listitem" id="list_lis0010"><dt class="label">•</dt><dd><p id="par0165">HIV-1 diversity has given rise to numerous subtypes and recombinant forms.</p></dd><dt class="label">•</dt><dd><p id="par0170">New subtyping tools (e.g. Rega HIV-1 Subtyping Tool version 3, SCUEL and COMET) can accurately identify the most important HIV-1 variants.</p></dd><dt class="label">•</dt><dd><p id="par0175">National and international public drug resistance databases are useful resources to trace the evolution of drug resistance in different subtypes.</p></dd><dt class="label">•</dt><dd><p id="par0180">HIV-1 subtype genetic variation can influence the development of drug resistance and the susceptibility to certain antiretroviral drugs.</p></dd><dt class="label">•</dt><dd><p id="par0185">K65R is an example of a clinically relevant mutation that emerges more frequently and more rapidly in subtype C viruses compared to subtype B; this has been shown to be related to the different template nucleotide sequence.</p></dd><dt class="label">•</dt><dd><p id="par0190">Evidence from recent clinical trials and cohort studies suggests that response to combination antiretroviral regimens does not differ substantially by HIV-1 subtype.</p></dd><dt class="label">•</dt><dd><p id="par0195">Appreciation of subtype differences is important in the development of new drugs and in the formulation of antiretroviral strategies.</p></dd></dl><p></p></div></div></div><!--VALIDHTML--><h2 class="svArticle" id="sec0010">HIV-1 origin, subtypes and recombinants</h2><p class="svArticle section" id="par0045">HIV-1 main group (group M) originated in West-Central Africa approximately 100 years ago [<sup><a href="#bib0020" id="bbib0020" class="intra_ref">4</a>&nbsp;and&nbsp;<a href="#bib0025" id="bbib0025" class="intra_ref">5••</a></sup>]. It has since diversified into a large number of variants, including nine subtypes (A–D, F–H, J–K), six subsubtypes (A1–A4, F1–F2), multiple (&gt;48) circulating recombinants forms (CRFs) and thousands of unique recombinant forms (URFs) (Los Alamos HIV Sequence Database; URL: <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.hiv.lanl.gov%252F" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.hiv.lanl.gov</a></span>) [<sup><a href="#bib0025" id="bbib0025" class="intra_ref">5••</a>&nbsp;and&nbsp;<a href="#bib0030" id="bbib0030" class="intra_ref">6</a></sup>]. The classification of recombinant viruses is based on complete genome analysis: CRFs are widespread, whereas URFs are restricted to a limited number of individuals [<span id="bbib0030"><a href="#bib0030" id="ancbbib0030" class="intra_ref">6</a></span>]. The high number of existing HIV-1 variants is caused by both biological and epidemiological factors, which have been recently reviewed [<sup><a href="#bib0020" id="bbib0020" class="intra_ref">4</a>, <a href="#bib0025" id="bbib0025" class="intra_ref">5••</a>&nbsp;and&nbsp;<a href="#bib0035" id="bbib0035" class="intra_ref">7</a></sup>].</p><!--VALIDHTML--><p class="svArticle section" id="par0050">HIV-1 variants are continually introduced into new populations by mobility and migration [<sup><a href="#bib0015" id="bbib0015" class="intra_ref">3</a>, <a href="#bib0025" id="bbib0025" class="intra_ref">5••</a>, <a href="#bib0030" id="bbib0030" class="intra_ref">6</a>&nbsp;and&nbsp;<a href="#bib0035" id="bbib0035" class="intra_ref">7</a></sup>]. As HIV-1 variants intermix in different part of the world, the likelihood of generating new recombinant viruses increases [<span id="bbib0030"><a href="#bib0030" id="ancbbib0030" class="intra_ref">6</a></span>]. For example, a recent study in Quebec, Canada identified four subtypes, three CRFs and two new URFs. One of the new URFs is a recombinant of A/B (the RT/protease region was largely of subtype A, the integrase was subtype B), which is spreading and may be classified as a new CRF once complete genomes are sequenced [<span id="bbib0040"><a href="#bib0040" id="ancbbib0040" class="intra_ref">8</a></span>]. Studies in London have detected all HIV-1 subtypes, the majority of CRFs and many previously undetected URFs [<a href="#bib0045" id="bbib0045" class="intra_ref">9</a>&nbsp;and&nbsp;<a href="#bib0050" id="bbib0050" class="intra_ref">10</a>]. Identification of individuals infected with different subtypes is increasing in metropolitan areas [<a href="#bib0040" id="bbib0040" class="intra_ref">8</a>&nbsp;and&nbsp;<a href="#bib0055" id="bbib0055" class="intra_ref">11</a>].</p><!--VALIDHTML--><h2 class="svArticle" id="sec0015">Subtyping tools and drug resistance databases</h2><p class="svArticle section" id="par0055">HIV-1 subtyping can be achieved by automated subtyping tools. At the time of this review, over 400&nbsp;000 isolates have been subtyped using the Rega HIV-1 subtyping tool. This tool uses phylogenetic analysis to identify subtypes and CRFs. A recent upgrade has allowed the identification of many new CRFs and, for the first time, the classification of URFs [Rega HIV Subtyping Tool V3; URL: <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.bioafrica.net%252F" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.bioafrica.net</a></span>]. <span id="bfig0005"><a href="#fig0005" id="ancbfig0005" class="intra_ref">Figure 1</a></span> shows a new feature of Rega Subtyping Tool V3, which is the phylogenetic identification of recombinant segments. A large comparison study of over 6000 sequences, carefully subtyped by phylogenetic methods, was conducted to evaluate the accuracy of REGAv3 and six other subtyping tools (ACP Pena <em>et al.</em> 17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology, Belgrade, Serbia, August 2012). The comparison tools included two new, sophisticated tools: SCUEL [<span id="bbib0060"><a href="#bib0060" id="ancbbib0060" class="intra_ref">12</a></span>] and COMET V2 (D Struck <em>et al.</em> 8th European HIV Drug Resistance Workshop, Sorrento, Italy, March 2010). The three tools identified most of the pure subtypes in <em>pol</em> with high sensitivity and specificity (&gt;95%). COMETv2 and REGAv3 identify the two most important CRFs (CRF01_AE and CRF02_AG) in more than 95%. Given that the great majority (&gt;90%) of the infections in the world are owing to subtypes A, B C, CRF01_AE and CRF02_AG [ <sup><a href="#bib0015" id="bbib0015" class="intra_ref">3</a>, <a href="#bib0025" id="bbib0025" class="intra_ref">5••</a>&nbsp;and&nbsp;<a href="#bib0035" id="bbib0035" class="intra_ref">7</a></sup>], these recent subtyping tools can accurately identify most of the epidemiologically important HIV-1 variants and classify new recombinants.</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="figure_fig0005"><div class="
                    textboxdefault
                "><dl class="figure" id="fig0005" data-t="f"><dt class="autoScroll" data-style="height:709px;width:769px;"><a class="figureLink" href="#gr1" title="Full-size image (114 K)"><img data-loaded="true" style="display: inline;" class="imgLazyJSB figure large smallImg" alt="Full-size image (114 K)" src="1-s2.0-S1879625712001320-gr1.jpg" data-thumbeid="1-s2.0-S1879625712001320-gr1.sml" data-fulleid="1-s2.0-S1879625712001320-gr1.jpg" data-thumbheight="164" data-thumbwidth="178" data-fullheight="709" data-fullwidth="769" border="0"><noscript class="figure large" border="0" alt="Full-size image" data-thumbeid="1-s2.0-S1879625712001320-gr1.sml" data-fulleid="1-s2.0-S1879625712001320-gr1.jpg"><img class="figure large" border="0" alt="Full-size image (114 K)" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S1879625712001320-gr1.jpg" data-thumbEID="1-s2.0-S1879625712001320-gr1.sml" data-fullEID="1-s2.0-S1879625712001320-gr1.jpg"></noscript></a></dt><dd id="labelCaptionfig0005"><p class="caption">Figure 1.&nbsp;<span id="spar0050">Recombination profile and phylogenies of recombinant regions of a CRF03_AB isolate 03 AB,RU,97,KAL153 2 [Rega HIV Subtyping Tool V3; URL: <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.bioafrica.net%252F" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.bioafrica.net</a></span>]. One of the new features of Rega Subtyping Tool version 3.0 is that it can perform detailed recombination analyses. The tool detects recombination, identifies the recombinant fragments and creates a phylogenetic tree fragments (Query sequence is at the top of the phylogenies). This figure shows a CRF recombinant A/B sequence (CRF03_AB, Genbank accession number <span class="interref" data-locatortype="ncbi-n"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=ncbi-n&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.ncbi.nlm.nih.gov%252Fentrez%252Fquery.fcgi%253Fcmd%253Dsearch%2526db%253Dnucleotide%2526doptcmdl%253Dgenbank%2526term%253DAF193276" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">AF193276</a></span>). The subtype A region is from position 2252 to 2782 (Protease amino acid position 1–99 and RT 1–78) and subtype B from 2782 to 4822 (RT amino acid position 79–440 and Integrase amino acid position 1–198). Numbering is performed based on the complete genome reference sequence HXB2.<!--Comment--></span><!--caption--></p></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Figure options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#fig0005" class="viewWS" title="View in workspace">View in workspace</a></li><li><a href="http://origin-ars.els-cdn.com/content/image/1-s2.0-S1879625712001320-gr1.jpg" title="View full-size image - Opens in new window">Download full-size image</a></li><li><a class="ppt" title="Download as PowerPoint slide" href="http://services.elsevier.com.libgate.library.nuigalway.ie/SDWebExport/export/figure/S1879625712001320/1-s2.0-S1879625712001320-gr1.jpg/ppt">Download as PowerPoint slide</a></li></ul></dd></dl></div></div><!--VALIDHTML--><p class="svArticle section" id="par0060">International and country specific drug resistance databases are important repositories of HIV-1 genetic data [<span id="bbib0065"><a href="#bib0065" id="ancbbib0065" class="intra_ref">13</a></span>]. The UK Drug Resistance Database contains over 10&nbsp;000 non-B subtype isolates and proposals can be submitted for the use of data [UK HIV Drug Resistance Database; URL: <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fwww.hivrdb.org.uk%252F" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://www.hivrdb.org.uk</a></span>]. The Stanford HIV Drug Resistance Database (HIVDB) curates all published data and contains nearly 150&nbsp;000 sequences. This is presented in many statistical and graphical formats [Stanford HIV Drug Resistance Database; URL: <span class="interref" data-locatortype="url"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=externObjLink&amp;_locator=url&amp;_issn=18796257&amp;_origin=article&amp;_zone=art_page&amp;_plusSign=%2B&amp;_targetURL=http%253A%252F%252Fhivdb.stanford.edu%252F" target="externObjLink" onclick="var newWidth=((window.screen.availWidth*90)/100);var newHeight=((window.screen.availHeight*90)/100);var parms = 'status=yes,location=yes,' + 'scrollbars=yes,resizable=yes,directories=yes,' + 'toolbar=yes,menubar=yes,' + 'width=' + newWidth + ',height=' + newHeight + ',screenX=10,screenY=10';var externalWin; externalWin=window.open('','externObjLink',parms); externalWin.focus()">http://hivdb.stanford.edu</a></span>]. HIVDB data and analyses have shown that, in spite of the large genetic variation found within subtypes, no major drug resistance mutation naturally occurs in naïve sequences [<a href="#bib0070" id="bbib0070" class="intra_ref">14</a>&nbsp;and&nbsp;<a href="#bib0075" id="bbib0075" class="intra_ref">15</a>]. However, a number of treatment-experienced mutation differences have been highlighted in the literature and are stored and curated in HIVDB. <span id="btbl0005"><a href="#tbl0005" id="ancbtbl0005" class="intra_ref">Table 1</a></span> summarises HIV drug resistance mutations associated with subtypes and CRFs in treatment experienced samples.</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="table_tbl0005"><div class="textboxdefault"><dl id="tbl0005" data-t="t" class="table " data-label="Table 1"><dd class="lblCap"><p class="caption"><span class="label">Table 1.
        </span>Recently described drug resistance mutations between HIV-1 subtypes and CRFs and impact on antiretroviral drug resistance and susceptibility</p></dd><dd class="table"><table><colgroup><col><col><col><col></colgroup><thead><tr><th rowspan="1" colspan="1">Position</th><th rowspan="1" colspan="1">Mutation</th><th rowspan="1" colspan="1">Comments</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="1" colspan="4"><em>Reverse transcriptase</em></td></tr><tr><td rowspan="1" colspan="1">RT65</td><td rowspan="1" colspan="1">K65R</td><td rowspan="1" colspan="1">Subtype C – AAG (K); subtype B – AAA (K): preferential pausing of reverse transcription, related to homopolymeric stretch of adenine bases</td><td rowspan="1" colspan="1">[<sup><a href="#bib0080" id="bbib0080" class="intra_ref">16</a>&nbsp;and&nbsp;<a href="#bib0085" id="bbib0085" class="intra_ref">17•</a></sup>]</td></tr><tr><td rowspan="1" colspan="1">RT138</td><td rowspan="1" colspan="1">E138K</td><td rowspan="1" colspan="1">E138K the first mutation to emerge in subtype C during etravirine therapy</td><td rowspan="1" colspan="1">[<span id="bbib0150"><a href="#bib0150" id="ancbbib0150" class="intra_ref">30</a></span>]</td></tr><tr><td rowspan="1" colspan="1">RT181</td><td rowspan="1" colspan="1">Y181C</td><td rowspan="1" colspan="1">Preferential selection of Y181C for subtype A and B during etravirine therapy</td><td rowspan="1" colspan="1">[<span id="bbib0155"><a href="#bib0155" id="ancbbib0155" class="intra_ref">31</a></span>]</td></tr><tr><td rowspan="1" colspan="1">RT348</td><td rowspan="1" colspan="1">N348I</td><td rowspan="1" colspan="1">Reduces susceptibility to etravirine in subtypes A, B and C. High prevalence in subtype C samples from patients failing first-generation NNRTIs</td><td rowspan="1" colspan="1">[<sup><a href="#bib0160" id="bbib0160" class="intra_ref">32</a>&nbsp;and&nbsp;<a href="#bib0165" id="bbib0165" class="intra_ref">33•</a></sup>]</td></tr><tr><td rowspan="1" colspan="4"><br></td></tr><tr><td rowspan="1" colspan="4"><em>Protease</em></td></tr><tr><td rowspan="1" colspan="1">PR17</td><td rowspan="1" colspan="1">G17E</td><td rowspan="1" colspan="1">CRF2_AG hypersusceptibility to nelfinavir, atazanavir and indinavir</td><td rowspan="1" colspan="1">[<span id="bbib0190"><a href="#bib0190" id="ancbbib0190" class="intra_ref">38</a></span>]</td></tr><tr><td rowspan="1" colspan="1">PR36</td><td rowspan="1" colspan="1">M36I</td><td rowspan="1" colspan="1">Subtype C – ATA (I); subtype B – ATG (M): affects susceptibility to protease inhibitors and viral replication capacity</td><td rowspan="1" colspan="1">[<span id="bbib0180"><a href="#bib0180" id="ancbbib0180" class="intra_ref">36</a></span>]</td></tr><tr><td rowspan="1" colspan="1">PR64</td><td rowspan="1" colspan="1">I64M</td><td rowspan="1" colspan="1">CRF2_AG hypersusceptibility to nelfinavir, atazanavir and indinavir</td><td rowspan="1" colspan="1">[<span id="bbib0190"><a href="#bib0190" id="ancbbib0190" class="intra_ref">38</a></span>]</td></tr><tr><td rowspan="1" colspan="1">PR89</td><td rowspan="1" colspan="1">M89T</td><td rowspan="1" colspan="1">Subtype C – ATG (M); subtype B – CTG (L): leads to preferential emergence of M89T in subtype C</td><td rowspan="1" colspan="1">[<span id="bbib0185"><a href="#bib0185" id="ancbbib0185" class="intra_ref">37</a></span>]</td></tr><tr><td rowspan="1" colspan="4"><br></td></tr><tr><td rowspan="1" colspan="4"><em>Integrase</em></td></tr><tr><td rowspan="1" colspan="1">IN92</td><td rowspan="1" colspan="1">E92Q</td><td rowspan="1" colspan="1">E92Q/N155H double mutant 10-fold more resistant to raltegravir and elvitegravir in subtype B versus subtype C</td><td rowspan="1" colspan="1">[<span id="bbib0235"><a href="#bib0235" id="ancbbib0235" class="intra_ref">47</a></span>]</td></tr><tr><td rowspan="1" colspan="1">IN101</td><td rowspan="1" colspan="1">L101I</td><td rowspan="1" colspan="1">Present more frequently in non-B subtypes compared to subtype B (both INI-naïve and RAL-experienced)</td><td rowspan="1" colspan="1">[<span id="bbib0240"><a href="#bib0240" id="ancbbib0240" class="intra_ref">48</a></span>]</td></tr><tr><td rowspan="1" colspan="1">IN118</td><td rowspan="1" colspan="1">G118R</td><td rowspan="1" colspan="1">Most common resistance pathway during dolutegravir therapy in subtype C</td><td rowspan="1" colspan="1">[<span id="bbib0250"><a href="#bib0250" id="ancbbib0250" class="intra_ref">50</a></span>]</td></tr><tr><td rowspan="1" colspan="1">IN124</td><td rowspan="1" colspan="1">T124A</td><td rowspan="1" colspan="1">Present more frequently in INI-naïve non-B subtypes compared to subtype B</td><td rowspan="1" colspan="1">[<span id="bbib0240"><a href="#bib0240" id="ancbbib0240" class="intra_ref">48</a></span>]</td></tr><tr><td rowspan="1" colspan="1">IN155</td><td rowspan="1" colspan="1">N155H</td><td rowspan="1" colspan="1">Subtype B with this mutation more resistant to raltegravir (and elvitegravir) than subtype C</td><td rowspan="1" colspan="1">[<span id="bbib0235"><a href="#bib0235" id="ancbbib0235" class="intra_ref">47</a></span>]</td></tr><tr><td rowspan="1" colspan="1">IN263</td><td rowspan="1" colspan="1">R263K</td><td rowspan="1" colspan="1">Most common resistance pathway during dolutegravir therapy in subtype B</td><td rowspan="1" colspan="1">[<span id="bbib0245"><a href="#bib0245" id="ancbbib0245" class="intra_ref">49<sup>•</sup></a></span>]</td></tr></tbody></table></dd><dd class="fullsizeTable"><a title="Full-size table - Opens new window" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiCaptionURL&amp;_method=retrieve&amp;_eid=1-s2.0-S1879625712001320&amp;_image=tbl0005&amp;_ba=&amp;_fmt=full&amp;_orig=na&amp;_issn=18796257&amp;_pii=S1879625712001320&amp;_isTablePopup=Y&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=65d25f4a894ddff0d2cca8d819ebb050">Full-size table</a></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Table options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#tbl0005" class="viewWS" title="View in workspace">View in workspace</a></li><li><div class="downloadCsv"><a title="Download as CSV" href="#">Download as CSV</a></div></li></ul></dd></dl></div></div><!--VALIDHTML--><h2 class="svArticle" id="sec0020">Nucleoside and nucleotide reverse transcriptase inhibitors</h2><p class="svArticle section" id="par0065">The lysine to arginine mutation at position 65 (K65R) is a major mutation that confers broad high-level resistance to most nucleoside/nucleotide reverse transcriptase inhibitors (NRTI/NtRTIs), except zidovudine. There is a substantial body of evidence that K65R emerges more frequently and more rapidly in subtype C viruses than in subtype B.</p><!--VALIDHTML--><p class="svArticle section" id="par0070">It has now been demonstrated that the difference in selection of K65R between subtypes B and C is related to the template nucleotide sequence and preferential pausing of reverse transcription at position 65. The nucleotide sequence at codons 64-65-66 differs between subtypes B and C and subtype C viruses contain a homopolymeric stretch of adenine bases. This leads to RT pausing during the synthesis of double-stranded DNA from the single-stranded DNA intermediate template, a process that is template-specific but independent of the RT enzyme [<span id="bbib0080"><a href="#bib0080" id="ancbbib0080" class="intra_ref">16</a></span>]. Subsequent misalignment of the template and primer leads to the AAG to AGG change responsible for the K65R mutation [<span id="bbib0085"><a href="#bib0085" id="ancbbib0085" class="intra_ref">17<sup>•</sup></a></span>].</p><!--VALIDHTML--><p class="svArticle section" id="par0075">Several recent studies have used ultra-deep pyrosequencing (UDPS) or allele-specific PCR (AS-PCR) to explore the frequency of low-level K65R mutants in both ART-naïve and ART-experienced individuals [<a href="#bib0090" id="bbib0090" class="intra_ref">18</a>, <a href="#bib0095" id="bbib0095" class="intra_ref">19</a>, <a href="#bib0100" id="bbib0100" class="intra_ref">20</a>, <a href="#bib0105" id="bbib0105" class="intra_ref">21</a>&nbsp;and&nbsp;<a href="#bib0110" id="bbib0110" class="intra_ref">22</a>]. In one study using UDPS, the frequency of K65R at both &gt;1% and &gt;0.4% levels was higher in subtype C compared to subtype B and non-B/non-C subtypes [<span id="bbib0090"><a href="#bib0090" id="ancbbib0090" class="intra_ref">18</a></span>]. In another study, the K65R mutation was detected at a higher frequency in ART-naïve subtype C individuals compared to those infected with subtype CRF01_AE (6% vs. 1%) and subtype B [<span id="bbib0095"><a href="#bib0095" id="ancbbib0095" class="intra_ref">19</a></span>]. In ART-experienced patients with virological failure and without K65R on conventional Sanger sequencing, one study detected the presence of K65R by AS-PCR in 13% (4/30) of patients [<span id="bbib0100"><a href="#bib0100" id="ancbbib0100" class="intra_ref">20</a></span>]; conversely other groups using UDPS detected no additional mutations in those without K65R on Sanger sequencing [<span id="bbib0105"><a href="#bib0105" id="ancbbib0105" class="intra_ref">21</a></span>]. It is important to note the limitations of these highly sensitive sequencing techniques and spurious detection of the K65R mutation through PCR-induced mutation has been demonstrated [<span id="bbib0110"><a href="#bib0110" id="ancbbib0110" class="intra_ref">22</a></span>].</p><!--VALIDHTML--><p class="svArticle section" id="par0080">There is recent clinical evidence demonstrating frequent and early emergence of K65R on tenofovir-based first-line ART regimens in South Africa [<span id="bbib0115"><a href="#bib0115" id="ancbbib0115" class="intra_ref">23<sup>•</sup></a></span>]. Recent analysis of large scale implementation of TDF, 3TC and NVP indicates a higher rate of virological failure with this regimen [<span id="bbib0120"><a href="#bib0120" id="ancbbib0120" class="intra_ref">24<sup>•</sup></a></span>]. In addition, a case report has documented the presence of low-level K65R mutants pre-treatment by clonal analysis, with enhancement of K65R variants within two months of treatment [<span id="bbib0125"><a href="#bib0125" id="ancbbib0125" class="intra_ref">25</a></span>]. There is an urgent need for further research to determine the prevalence and impact of low-level K65R mutants, especially in settings where subtype C predominates and where tenofovir is now a component of first-line ART regimens.</p><!--VALIDHTML--><h2 class="svArticle" id="sec0025">Non-nucleoside reverse transcriptase inhibitors</h2><p class="svArticle section" id="par0085">The emergence of non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance mutation occurs after single dose nevirapine (sdNVP) for the prevention of mother-to-child HIV transmission. Previous work has suggested that this occurs more frequently with subtype C viruses [<a href="#bib0130" id="bbib0130" class="intra_ref">26</a>&nbsp;and&nbsp;<a href="#bib0135" id="bbib0135" class="intra_ref">27</a>]. One more recent study showed that resistance mutations could be demonstrated using AS-PCR in 25% of patients more than 24 months after sdNVP exposure (C Yang <em>et al.</em> 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, February 2010). However, the clinical significance of this is uncertain as the same study demonstrated no association between the presence of resistance mutations and virological failure on a subsequent NNRTI-based regimen (PJ Weidle <em>et al.</em> 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, February 2010).</p><!--VALIDHTML--><p class="svArticle section" id="par0090">Etravirine is a second-generation NNRTI which retains activity against strains with some resistance to nevirapine and efavirenz and which might therefore be an option as a component of a salvage regimen for antiretroviral-experienced patients. It has demonstrated good efficacy across subtypes [<span id="bbib0140"><a href="#bib0140" id="ancbbib0140" class="intra_ref">28</a></span>]. There are a number of etravirine resistance-associated mutations (RAMs) which reduce the response to etravirine. These mutations are commonly present as polymorphisms in ART-naïve individuals infected with non-B subtypes, especially CRF02_AG [<span id="bbib0145"><a href="#bib0145" id="ancbbib0145" class="intra_ref">29</a></span>]. There is conflicting evidence on the resistance pathways selected by etravirine therapy. One study found E138K the first mutation to emerge in subtypes B, C and CRF02_AG [<span id="bbib0150"><a href="#bib0150" id="ancbbib0150" class="intra_ref">30</a></span>]. A separate study found the same for subtype C but demonstrated preferential selection of Y181C for subtype B virus [<span id="bbib0155"><a href="#bib0155" id="ancbbib0155" class="intra_ref">31</a></span>].</p><!--VALIDHTML--><p class="svArticle section" id="par0095">A novel mutation in the C-terminal domain of RT (N348I) has recently been reported to reduce susceptibility to etravirine in subtypes A, B and C [<span id="bbib0160"><a href="#bib0160" id="ancbbib0160" class="intra_ref">32</a></span>]. One clinical trial in South Africa found the N348I mutation present in 24% of patients failing first-line NNRTI regimens with subtype C virus, most commonly with nevirapine [<span id="bbib0165"><a href="#bib0165" id="ancbbib0165" class="intra_ref">33<sup>•</sup></a></span>]. This mutation is not included in standard mutation lists or algorithms but more data are urgently required to determine clinical relevance.</p><!--VALIDHTML--><p class="svArticle section" id="par0100">Rilpivirine (RPV) is another second-generation NNRTI with equal efficacy and similar patterns of resistance across subtypes [<a href="#bib0170" id="bbib0170" class="intra_ref">34</a>&nbsp;and&nbsp;<a href="#bib0175" id="bbib0175" class="intra_ref">35</a>]. However, regardless of subtype, RPV has suboptimal efficacy compared to efavirenz in ART-naïve individuals with HIV RNA &gt;100&nbsp;000 copies/ml [<span id="bbib0175"><a href="#bib0175" id="ancbbib0175" class="intra_ref">35</a></span>].</p><!--VALIDHTML--><h2 class="svArticle" id="sec0030">Protease inhibitors</h2><p class="svArticle section" id="par0105">Non-polymorphic mutations in the protease gene have a greater impact on baseline susceptibility to protease inhibitors than polymorphic mutations [<span id="bbib0075"><a href="#bib0075" id="ancbbib0075" class="intra_ref">15</a></span>]. However, recent evidence has suggested that the polymorphism at codon 36 in the protease gene (M36 in subtype B and I36 in most other subtypes) affects both the patterns of resistance that emerge under drug pressure and viral replication capacity [<span id="bbib0180"><a href="#bib0180" id="ancbbib0180" class="intra_ref">36</a></span>]. Similarly, the M89 polymorphism in subtypes A, C, and CRF01_AE (L89 in subtype B) preferentially leads to the emergence under drug pressure of the M89T mutation, which confers high-level resistance to nelfinavir, atazanavir and lopinavir [<span id="bbib0185"><a href="#bib0185" id="ancbbib0185" class="intra_ref">37</a></span>]. There is also <em>in vitro</em> evidence that CRF2_AG viruses with the 17E/64M polymorphisms demonstrate hypersusceptibility to certain protease inhibitors (nelfinavir, atazanavir and indinavir) [<span id="bbib0190"><a href="#bib0190" id="ancbbib0190" class="intra_ref">38</a></span>].</p><!--VALIDHTML--><p class="svArticle section" id="par0110">Mutations in the <em>gag</em> cleavage sites and gag matrix protein are known to contribute to protease inhibitor resistance. Polymorphisms in this region may be more common in non-B subtypes [ <a href="#bib0195" id="bbib0195" class="intra_ref">39</a>&nbsp;and&nbsp;<a href="#bib0200" id="bbib0200" class="intra_ref">40</a>] and have been shown to affect virological outcomes with lopinavir/ritonavir monotherapy [<span id="bbib0205"><a href="#bib0205" id="ancbbib0205" class="intra_ref">41</a></span>]. The importance of the subtype differences in <em>gag</em> are not well defined but may be more important in boosted PI monotherapy, which is under investigation for second-line therapy in resource-limited settings [<span id="bbib0210"><a href="#bib0210" id="ancbbib0210" class="intra_ref">42</a></span>].</p><!--VALIDHTML--><h2 class="svArticle" id="sec0035">Integrase inhibitors</h2><p class="svArticle section" id="par0115">Raltegravir, a first-generation integrase inhibitor (INI), has demonstrated good efficacy in ART-naïve and ART-experienced individuals infected with different HIV-1 subtypes [<span id="bbib0215"><a href="#bib0215" id="ancbbib0215" class="intra_ref">43</a></span>]. However, both raltegravir and the other first-generation INI elvitegravir have a relatively low genetic barrier to resistance. The primary mutations in the integrase gene associated with INI resistance are E92Q, Y143R/C, Q148K/R/H and N155H. The residues associated with primary resistance seem to be highly conserved across subtypes, but polymorphisms at the sites of secondary mutations are more common in non-B subtypes [<a href="#bib0040" id="bbib0040" class="intra_ref">8</a>, <a href="#bib0220" id="bbib0220" class="intra_ref">44</a>, <a href="#bib0225" id="bbib0225" class="intra_ref">45</a>&nbsp;and&nbsp;<a href="#bib0230" id="bbib0230" class="intra_ref">46</a>]. There is some evidence that the effect of certain integrase mutations might differ according to subtype. Subtype B integrase enzyme with the N155H mutation (±E92Q) exhibited increased resistance to raltegravir compared to the subtype C enzyme [<span id="bbib0235"><a href="#bib0235" id="ancbbib0235" class="intra_ref">47</a></span>].</p><!--VALIDHTML--><p class="svArticle section" id="par0120">Dolutegravir and MK-2048 are second-generation integrase inhibitors in development that have higher genetic barriers to resistance and retain activity against viruses with resistance to raltegravir or elvitegravir. There is some early evidence to suggest subtype differences could modulate the emergence of resistance to these drugs. In both INI naïve and raltegravir-experienced individuals, polymorphisms at codons 101 and 124 were more frequent in non-B subtypes than subtype B; these mutations were particularly prevalent in subtypes C and CRF02_AG [<span id="bbib0240"><a href="#bib0240" id="ancbbib0240" class="intra_ref">48</a></span>]. Whilst the R263K mutation seems to be the most common mutation selected during dolutegravir therapy in subtype B, the G118R mutation previously associated with MK-2048 resistance might be a more common pathway in subtype C [<sup><a href="#bib0245" id="bbib0245" class="intra_ref">49•</a>&nbsp;and&nbsp;<a href="#bib0250" id="bbib0250" class="intra_ref">50</a></sup>].</p><!--VALIDHTML--><h2 class="svArticle" id="sec0040">Clinical efficacy of new antiretroviral agents by HIV-1 subtype</h2><p class="svArticle section" id="par0125">Clinical evidence of different subtype responses to antiretroviral therapy (ART) might be the first indicator of subtype differences in the development of drug resistance. Inclusion of individuals infected with different subtypes is increasingly the norm in clinical trials of new antiretroviral agents, although the numbers infected with some non-B subtypes are quite low. <span id="btbl0010"><a href="#tbl0010" id="ancbtbl0010" class="intra_ref">Table 2</a></span> shows the virological responses by HIV-1 subtype in recently published clinical trials of new antiretroviral agents.</p><!--VALIDHTML--><div class="figTblUpiOuter svArticle" id="table_tbl0010"><div class="textboxdefault"><dl id="tbl0010" data-t="t" class="table " data-label="Table 2"><dd class="lblCap"><p class="caption"><span class="label">Table 2.
        </span>Virological outcomes with specific antiretroviral drugs across different HIV-1 subtypes. Virological outcomes reported only for regimen including investigational drug, except for ARTEMIS where lopinavir and darunavir both reported</p></dd><dd class="table"><table><colgroup><col><col><col><col><col><col></colgroup><thead><tr><th rowspan="1" colspan="6">Clinical trials<hr></th></tr><tr><th rowspan="1" colspan="1">Drug name</th><th rowspan="1" colspan="1">Clinical trial(s)</th><th rowspan="1" colspan="1">Patient population</th><th rowspan="1" colspan="1">Participants (by subtype)</th><th rowspan="1" colspan="1">Virological outcomes<span id="btblfn0005"><a href="#tblfn0005" id="ancbtblfn0005" class="intra_ref"><sup>a</sup></a></span></th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Lopinavir</td><td rowspan="1" colspan="1">ARTEMIS</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">208 subtype B<br>50 subtype C<br>87 other subtypes</td><td rowspan="1" colspan="1">78% subtype B<br>82% subtype C<br>78% other subtypes</td><td rowspan="1" colspan="1">Dierynck 2010 [<span id="bbib0265"><a href="#bib0265" id="ancbbib0265" class="intra_ref">53</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Darunavir</td><td rowspan="1" colspan="1">ARTEMIS</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">210 subtype B<br>39 subtype C<br>93 other subtypes</td><td rowspan="1" colspan="1">81% subtype B<br>87% subtype C<br>88% other subtypes</td><td rowspan="1" colspan="1">Dierynck 2010 [<span id="bbib0265"><a href="#bib0265" id="ancbbib0265" class="intra_ref">53</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Etravirine</td><td rowspan="1" colspan="1">DUET-1, DUET-2</td><td rowspan="1" colspan="1">ART experienced</td><td rowspan="1" colspan="1">561 subtype B<br>33 non-B subtypes (no subtype C)</td><td rowspan="1" colspan="1">60% subtype B<br>73% non-B subtypes</td><td rowspan="1" colspan="1">Vingerhouts 2010 [<span id="bbib0140"><a href="#bib0140" id="ancbbib0140" class="intra_ref">28</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Rilpivirine</td><td rowspan="1" colspan="1">ECHO, THRIVE</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">485 subtype B<br>76 subtype C<br>125 other subtypes</td><td rowspan="1" colspan="1">84% subtype B<br>86% subtype C<br>86% other subtypes</td><td rowspan="1" colspan="1">Cohen 2012 [<span id="bbib0170"><a href="#bib0170" id="ancbbib0170" class="intra_ref">34</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Maraviroc</td><td rowspan="1" colspan="1">MERIT</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">Not reported</td><td rowspan="1" colspan="1">70% subtype B<br>61% subtype C<br>57% other subtypes</td><td rowspan="1" colspan="1">Cooper 2010 [<span id="bbib0270"><a href="#bib0270" id="ancbbib0270" class="intra_ref">54</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Raltegravir</td><td rowspan="1" colspan="1">STARTMRK</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">219 subtype B<br>19 subtype C<br>32 other subtypes</td><td rowspan="1" colspan="1">89% subtype B<span id="btblfn0010"><a href="#tblfn0010" id="ancbtblfn0010" class="intra_ref"><sup>b</sup></a></span><br>95% non-B subtypes<span id="btblfn0010"><a href="#tblfn0010" id="ancbtblfn0010" class="intra_ref"><sup>b</sup></a></span></td><td rowspan="1" colspan="1">Rockstroh 2011 [<span id="bbib0215"><a href="#bib0215" id="ancbbib0215" class="intra_ref">43</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Raltegravir</td><td rowspan="1" colspan="1">BENCHMRK-1, BENCHMRK-2</td><td rowspan="1" colspan="1">ART experienced</td><td rowspan="1" colspan="1">416 subtype B<br>3 subtype C<br>33 other subtypes</td><td rowspan="1" colspan="1">61% subtype B<span id="btblfn0010"><a href="#tblfn0010" id="ancbtblfn0010" class="intra_ref"><sup>b</sup></a></span><br>67% non-B subtypes<span id="btblfn0010"><a href="#tblfn0010" id="ancbtblfn0010" class="intra_ref"><sup>b</sup></a></span></td><td rowspan="1" colspan="1">Rockstroh 2011 [<span id="bbib0215"><a href="#bib0215" id="ancbbib0215" class="intra_ref">43</a></span>]</td></tr></tbody></table></dd><dd class="table"><table><thead><tr><th rowspan="1" colspan="6">Cohort studies<hr></th></tr><tr><th rowspan="1" colspan="1">Cohort</th><th rowspan="1" colspan="1">Drug regimens</th><th rowspan="1" colspan="1">Patient population</th><th rowspan="1" colspan="1">Participants (by subtype)</th><th rowspan="1" colspan="1">Virological outcomes</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">UK CHIC</td><td rowspan="1" colspan="1">2 NRTI&nbsp;+&nbsp;NNRTI<br>2 NRTI&nbsp;+&nbsp;boosted PI</td><td rowspan="1" colspan="1">ART naïve</td><td rowspan="1" colspan="1">1550 subtype B<br>272 subtype C<br>66 subtype A</td><td rowspan="1" colspan="1">89% subtype B<span id="btblfn0015"><a href="#tblfn0015" id="ancbtblfn0015" class="intra_ref"><sup>c</sup></a></span><br>94% subtype C<span id="btblfn0015"><a href="#tblfn0015" id="ancbtblfn0015" class="intra_ref"><sup>c</sup></a></span><br>97% subtype A<span id="btblfn0015"><a href="#tblfn0015" id="ancbtblfn0015" class="intra_ref"><sup>c</sup></a></span></td><td rowspan="1" colspan="1">Geretti 2009 [<span id="bbib0255"><a href="#bib0255" id="ancbbib0255" class="intra_ref">51</a></span>]</td></tr><tr><td rowspan="1" colspan="1">Swiss HIV cohort</td><td rowspan="1" colspan="1">Various</td><td rowspan="1" colspan="1">ART naïve and mono/dual-NRTI experienced</td><td rowspan="1" colspan="1">2166 subtype B<br>383 non-B subtypes</td><td rowspan="1" colspan="1">89% subtype B<span id="btblfn0020"><a href="#tblfn0020" id="ancbtblfn0020" class="intra_ref"><sup>d</sup></a></span><br>90% non-B subtypes<span id="btblfn0020"><a href="#tblfn0020" id="ancbtblfn0020" class="intra_ref"><sup>d</sup></a></span></td><td rowspan="1" colspan="1">Scherrer 2011 [<span id="bbib0260"><a href="#bib0260" id="ancbbib0260" class="intra_ref">52<sup>•</sup></a></span>]</td></tr></tbody></table></dd><dd><dl id="tblfn0005" data-t="n" class="tblFootnote"><dt>a</dt><dd><p>Outcome HIV RNA &lt;50 copies/ml at week 48 unless otherwise stated.</p></dd></dl><dl id="tblfn0010" data-t="n" class="tblFootnote"><dt>b</dt><dd><p>HIV RNA &lt;50 copies/ml at week 96; data not reported separately for subtype C.</p></dd></dl><dl id="tblfn0015" data-t="n" class="tblFootnote"><dt>c</dt><dd><p>HIV RNA &lt;50 copies/ml at 12 months.</p></dd></dl><dl id="tblfn0020" data-t="n" class="tblFootnote"><dt>d</dt><dd><p>HIV RNA &lt;50 copies/ml 90–365 days after ART initiation; results only shown for those who started ART 1999–2009.</p></dd></dl></dd><dd class="fullsizeTable"><a title="Full-size table - Opens new window" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=MiamiCaptionURL&amp;_method=retrieve&amp;_eid=1-s2.0-S1879625712001320&amp;_image=tbl0010&amp;_ba=&amp;_fmt=full&amp;_orig=na&amp;_issn=18796257&amp;_pii=S1879625712001320&amp;_isTablePopup=Y&amp;_acct=C000007922&amp;_version=1&amp;_urlVersion=0&amp;_userid=103680&amp;md5=07b693f26c4aa6a8f297600acf175d53">Full-size table</a></dd><dd class="menuButtonLinks"><div class="btnHolder"><a class="menuTitle" href="#">Table options</a><div class="down_Btn"></div></div><ul class="menuButton"><li><a href="#tbl0010" class="viewWS" title="View in workspace">View in workspace</a></li><li><div class="downloadCsv"><a title="Download as CSV" href="#">Download as CSV</a></div></li></ul></dd></dl></div></div><!--VALIDHTML--><p class="svArticle section" id="par0130">Cohort studies can also provide evidence of subtype differences in ART responses, although this is complicated by the use of different ART regimens. A collaborative group in the UK found that virological outcomes were broadly similar between subtypes A, B and C [<span id="bbib0255"><a href="#bib0255" id="ancbbib0255" class="intra_ref">51</a></span>], while a more recent study from the Swiss HIV Cohort Study, which restricted analysis to white Caucasians, reported that those infected with non-B subtypes, had a lower risk of virological failure which was particularly apparent for subtypes A and CRF02_AG [<span id="bbib0260"><a href="#bib0260" id="ancbbib0260" class="intra_ref">52<sup>•</sup></a></span>].</p><!--VALIDHTML--><h2 class="svArticle" id="sec0045">Conclusions</h2><p class="svArticle section" id="par0135">There is no compelling evidence that HIV-1 subtype needs be considered in the choice of ART regimens for first-line or second-line therapy, and other considerations of cost, effectiveness, toxicities and tolerability are more important in low-income and middle-income countries. However, recent evidence of subtype differences in drug resistance could potentially impact on antiretroviral strategies. The large amount of resistance data produced as part of surveillance studies and clinical care can be used to explore the differences in drug resistance between HIV-1 subtypes. National HIV drug resistance databases such as the ones in the UK, Switzerland and, recently, the Southern African Treatment and Resistance Network (SATuRN) Stanford and Rega public drug resistance databases are very useful national strategic resources to tackle the spread of drug resistance. The appreciation of subtype differences is also important to the development of new drugs, treatment strategies, drug sequencing, assessing response to treatment and surveillance for the transmission of resistance. In each of these areas, and in tracking the evolution of the HIV-1 pandemic, differences among subtypes continue to play an important role.</p><!--VALIDHTML--><h2 class="svArticle" id="sec0050">References and recommended reading</h2><p class="svArticle section" id="par0140">Papers of particular interest, published within the period of review, have been highlighted as:</p><dl class="listitem" id="list_lis0005"><dd><p id="par0145">• of special interest</p></dd><dd><p id="par0150">•• of outstanding interest</p></dd></dl><p></p><!--VALIDHTML--><div class="articleText svArticle"><div class="articleText_indent"><h2 class="h2 secHeading" id="ack001">Acknowledgements</h2><p class="svArticle section" id="par0155">RJL is supported by the <span id="gs0005"><!--Comment--></span>Wellcome Trust [grant number <a href="#gs0005">090999</a>]. TdO is supported by the Wellcome Trust [grant number <a href="#gs0005">082384</a>] and the grant entitled “Swiss-Prot/South Africa: Protein Bioinformatics Resource Development for Important Health-related Pathogens” under the <span id=""><!--Comment--></span>Switzerland-South Africa Collaborative Research Program. European Commission (SANTE 2007 147–790).</p></div></div><!--VALIDHTML--><script type="text/javascript">

              prs.rt("ref_start");
            </script><h2 id="bibl00bibl0005">References</h2><ol class="references"><li id="bib0005" data-t="r"><ul class="reference" id="bibsbref1"><li class="referenceLabel"><a href="#bib0005" class="label intra_ref">1</a></li><li class="author"> Joint United Nations Programme on HIV/AIDS (UNAIDS)</li><li class="title"><p>World AIDS Day Report 2011</p></li><li class="source"><p>UNAIDS, Geneva, Switzerland (2011)</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref1" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref1'] = new Array();
        </script></li><li id="bib0010" data-t="r"><ul class="reference" id="bibsbref2"><li class="referenceLabel"><a href="#bib0010" class="label intra_ref">2</a></li><li class="author">R.L. Hamers, C. Kityo, J.M. Lange, T.F. Wit, P. Mugyenyi</li><li class="title"><p>Global threat from drug resistant HIV in sub-Saharan Africa</p></li><li class="source"><p>BMJ, 344 (2012), p. e4159</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref2" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref2'] = new Array();
        </script></li><li id="bib0015" data-t="r"><ul class="reference" id="bibsbref3"><li class="referenceLabel"><a href="#bib0015" class="label intra_ref">3</a></li><li class="author">J. Hemelaar, E. Gouws, P.D. Ghys, S. Osmanov</li><li class="title"><p>Global trends in molecular epidemiology of HIV-1 during 2000–2007</p></li><li class="source"><p>AIDS, 25 (2011), pp. 679–689</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref3" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref3'] = new Array();
        </script></li><li id="bib0020" data-t="r"><ul class="reference" id="bibsbref4"><li class="referenceLabel"><a href="#bib0020" class="label intra_ref">4</a></li><li class="author">P.M. Sharp, B.H. Hahn</li><li class="title"><p>The evolution of HIV-1 and the origin of AIDS</p></li><li class="source"><p>Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, 365 (2010), pp. 2487–2494</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref4" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref4'] = new Array();
        </script></li><li id="bib0025" data-t="r"><ul class="reference" id="bibsbref5"><li class="referenceLabel"><a href="#bib0025" class="label intra_ref">5••</a></li><li class="author">D.M. Tebit, E.J. Arts</li><li class="title"><p>Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease</p></li><li class="source"><p>Lancet Infectious Diseases, 11 (2011), pp. 45–56</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref5" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref5'] = new Array();
        </script><ul class="reference" id="bibsbref6"><li class="referenceLabel"><a href="#bib0025" class="label intra_ref">5••</a></li><li class="source"><p id="spar0015">Excellent overview of HIV-1 evolution, with particular focus on recombination.</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref6" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref6'] = new Array();
        </script></li><li id="bib0030" data-t="r"><ul class="reference" id="bibsbref7"><li class="referenceLabel"><a href="#bib0030" class="label intra_ref">6</a></li><li class="author">M. Peeters, A.F. Aghokeng, E. Delaporte</li><li class="title"><p>Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays</p></li><li class="source"><p>Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 16 (2010), pp. 1525–1531</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref7" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref7'] = new Array();
        </script></li><li id="bib0035" data-t="r"><ul class="reference" id="bibsbref8"><li class="referenceLabel"><a href="#bib0035" class="label intra_ref">7</a></li><li class="author">J. Hemelaar</li><li class="title"><p>The origin and diversity of the HIV-1 pandemic</p></li><li class="source"><p>Trends in Molecular Medicine, 18 (2012), pp. 182–192</p></li><li data-sr="Y" class="external refPlaceHolder" id="bibsbref8" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref8'] = new Array();
        </script></li><li id="bib0040" data-t="r"><ul class="reference" id="bibsbref9"><li class="referenceLabel"><a href="#bib0040" class="label intra_ref">8</a></li><li class="author">B.G. Brenner, M. Lowe, D. Moisi, I. Hardy, S. Gagnon, H. Charest, J.G. Baril, M.A. Wainberg, M. Roger</li><li class="title"><p>Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors</p></li><li class="source"><p>Journal of Medical Virology, 83 (2011), pp. 751–759</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref9" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref9'] = new Array();
        </script></li><li id="bib0045" data-t="r"><ul class="reference" id="bibsbref10"><li class="referenceLabel"><a href="#bib0045" class="label intra_ref">9</a></li><li class="author">D.N. Chilton, H. Castro, S. Lattimore, L.J. Harrison, E. Fearnhill, V. Delpech, B. Rice, D. Pillay, D.T. Dunn</li><li class="title"><p>HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom</p></li><li class="source"><p>Antiviral Therapy, 15 (2010), pp. 985–991</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref10" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref10'] = new Array();
        </script></li><li id="bib0050" data-t="r"><ul class="reference" id="bibsbref11"><li class="referenceLabel"><a href="#bib0050" class="label intra_ref">10</a></li><li class="author">J. Fox, H. Castro, S. Kaye, M. McClure, J.N. Weber, S. Fidler</li><li class="title"><p>Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK</p></li><li class="source"><p>AIDS, 24 (2010), pp. 2397–2401</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref11" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref11'] = new Array();
        </script></li><li id="bib0055" data-t="r"><ul class="reference" id="bibsbref12"><li class="referenceLabel"><a href="#bib0055" class="label intra_ref">11</a></li><li class="author">M.A. Wainberg, G.J. Zaharatos, B.G. Brenner</li><li class="title"><p>Development of antiretroviral drug resistance</p></li><li class="source"><p>New England Journal of Medicine, 365 (2011), pp. 637–646</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref12" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref12'] = new Array();
        </script></li><li id="bib0060" data-t="r"><ul class="reference" id="bibsbref13"><li class="referenceLabel"><a href="#bib0060" class="label intra_ref">12</a></li><li class="author">S.L. Kosakovsky Pond, D. Posada, E. Stawiski, C. Chappey, A.F. Poon, G. Hughes, E. Fearnhill, M.B. Gravenor, A.J. Leigh Brown, S.D. Frost</li><li class="title"><p>An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1</p></li><li class="source"><p>PLoS Computational Biology, 5 (2009), p. e1000581</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref13" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref13'] = new Array();
        </script></li><li id="bib0065" data-t="r"><ul class="reference" id="bibsbref14"><li class="referenceLabel"><a href="#bib0065" class="label intra_ref">13</a></li><li class="author">T. de Oliveira, R.W. Shafer, C. Seebregts</li><li class="title"><p>Public database for HIV drug resistance in southern Africa</p></li><li class="source"><p>Nature, 464 (2010), p. 673</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref14" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref14'] = new Array();
        </script></li><li id="bib0070" data-t="r"><ul class="reference" id="bibsbref15"><li class="referenceLabel"><a href="#bib0070" class="label intra_ref">14</a></li><li class="author">G.L. Melikian, S.Y. Rhee, J. Taylor, W.J. Fessel, D. Kaufman, W. Towner, P.V. Troia-Cancio, A. Zolopa, G.K. Robbins, R. Kagan <em>et al.</em></li><li class="title"><p>Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 56 (2012), pp. 2305–2313</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref15" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref15'] = new Array();
        </script></li><li id="bib0075" data-t="r"><ul class="reference" id="bibsbref16"><li class="referenceLabel"><a href="#bib0075" class="label intra_ref">15</a></li><li class="author">S.Y. Rhee, J. Taylor, W.J. Fessel, D. Kaufman, W. Towner, P. Troia, P. Ruane, J. Hellinger, V. Shirvani, A. Zolopa <em>et al.</em></li><li class="title"><p>HIV-1 protease mutations and protease inhibitor cross-resistance</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 54 (2010), pp. 4253–4261</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref16" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref16'] = new Array();
        </script></li><li id="bib0080" data-t="r"><ul class="reference" id="bibsbref17"><li class="referenceLabel"><a href="#bib0080" class="label intra_ref">16</a></li><li class="author">D. Coutsinos, C.F. Invernizzi, H. Xu, B.G. Brenner, M.A. Wainberg</li><li class="title"><p>Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1</p></li><li class="source"><p>Antiviral Chemistry and Chemotherapy, 20 (2010), pp. 117–131</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref17" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref17'] = new Array();
        </script></li><li id="bib0085" data-t="r"><ul class="reference" id="bibsbref18"><li class="referenceLabel"><a href="#bib0085" class="label intra_ref">17•</a></li><li class="author">D. Coutsinos, C.F. Invernizzi, D. Moisi, M. Oliveira, J.L. Martinez-Cajas, B.G. Brenner, M.A. Wainberg</li><li class="title"><p>A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1</p></li><li class="source"><p>PLoS ONE, 6 (2011), p. e20208</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref18" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref18'] = new Array();
        </script><ul class="reference" id="bibsbref19"><li class="referenceLabel"><a href="#bib0085" class="label intra_ref">17•</a></li><li class="source"><p id="spar0020">Provides clear and detailed explanation for emergence of K65R in subtype C.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref19" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref19'] = new Array();
        </script></li><li id="bib0090" data-t="r"><ul class="reference" id="bibsbref20"><li class="referenceLabel"><a href="#bib0090" class="label intra_ref">18</a></li><li class="author">M.J. Kozal, J. Chiarella, E.P. St John, E.A. Moreno, B.B. Simen, T.E. Arnold, M. Lataillade</li><li class="title"><p>Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels</p></li><li class="source"><p>Antiviral Therapy, 16 (2011), pp. 925–929</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref20" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref20'] = new Array();
        </script></li><li id="bib0095" data-t="r"><ul class="reference" id="bibsbref21"><li class="referenceLabel"><a href="#bib0095" class="label intra_ref">19</a></li><li class="author">J.F. Li, J.T. Lipscomb, X. Wei, N.A. Martinson, L. Morris, W. Heneine, J.A. Johnson</li><li class="title"><p>Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections</p></li><li class="source"><p>Journal of Infectious Diseases, 203 (2011), pp. 798–802</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref21" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref21'] = new Array();
        </script></li><li id="bib0100" data-t="r"><ul class="reference" id="bibsbref22"><li class="referenceLabel"><a href="#bib0100" class="label intra_ref">20</a></li><li class="author">T.A. Toni, B.G. Brenner, E.L. Asahchop, M. Ntemgwa, D. Moisi, M.A. Wainberg</li><li class="title"><p>Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 54 (2010), pp. 907–911</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref22" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref22'] = new Array();
        </script></li><li id="bib0105" data-t="r"><ul class="reference" id="bibsbref23"><li class="referenceLabel"><a href="#bib0105" class="label intra_ref">21</a></li><li class="author">P. Recordon-Pinson, J. Papuchon, S. Reigadas, A. Deshpande, H. Fleury</li><li class="title"><p>K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data</p></li><li class="source"><p>PLoS ONE, 7 (2012), p. e36549</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref23" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref23'] = new Array();
        </script></li><li id="bib0110" data-t="r"><ul class="reference" id="bibsbref24"><li class="referenceLabel"><a href="#bib0110" class="label intra_ref">22</a></li><li class="author">V. Varghese, E. Wang, F. Babrzadeh, M.H. Bachmann, R. Shahriar, T. Liu, S.J. Mappala, B. Gharizadeh, W.J. Fessel, D. Katzenstein <em>et al.</em></li><li class="title"><p>Nucleic acid template and the risk of a PCR-induced HIV-1 drug resistance mutation</p></li><li class="source"><p>PLoS ONE, 5 (2010), p. e10992</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref24" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref24'] = new Array();
        </script></li><li id="bib0115" data-t="r"><ul class="reference" id="bibsbref25"><li class="referenceLabel"><a href="#bib0115" class="label intra_ref">23•</a></li><li class="author">H. Sunpath, B. Wu, M. Gordon, J. Hampton, B. Johnson, M.Y. Moosa, C. Ordonez, D.R. Kuritzkes, V.C. Marconi</li><li class="title"><p>High rate of K65R for ART naive patients with subtype C HIV infection failing a TDF-containing first-line regimen in South Africa</p></li><li class="source"><p>AIDS, 26 (2012), pp. 1679–1684</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref25" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref25'] = new Array();
        </script><ul class="reference" id="bibsbref26"><li class="referenceLabel"><a href="#bib0115" class="label intra_ref">23•</a></li><li class="source"><p id="spar0025">Concerning report from South Africa of very early development of K65R associated with virological failure of first-line ART regimens.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref26" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref26'] = new Array();
        </script></li><li id="bib0120" data-t="r"><ul class="reference" id="bibsbref27"><li class="referenceLabel"><a href="#bib0120" class="label intra_ref">24•</a></li><li class="author">M.W. Tang, P.J. Kanki, R.W. Shafer</li><li class="title"><p>A review of the virological efficacy of the 4 world health organization-recommended tenofovir-containing regimens for initial HIV therapy</p></li><li class="source"><p>Clinical Infectious Diseases, 54 (2012), pp. 862–875</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref27" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref27'] = new Array();
        </script><ul class="reference" id="bibsbref28"><li class="referenceLabel"><a href="#bib0120" class="label intra_ref">24•</a></li><li class="source"><p id="spar0030">A systematic review which finds evidence that regimens containing tenofovir and nevirapine might have suboptimal potency.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref28" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref28'] = new Array();
        </script></li><li id="bib0125" data-t="r"><ul class="reference" id="bibsbref29"><li class="referenceLabel"><a href="#bib0125" class="label intra_ref">25</a></li><li class="author">V. Bansal, K.J. Metzner, B. Niederost, C. Leemann, J. Boni, H.F. Gunthard, J.S. Fehr</li><li class="title"><p>Minority K65R variants and early failure of antiretroviral therapy in HIV-1-infected Eritrean immigrant</p></li><li class="source"><p>Emerging Infectious Diseases, 17 (2011), pp. 1966–1968</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref29" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref29'] = new Array();
        </script></li><li id="bib0130" data-t="r"><ul class="reference" id="bibsbref30"><li class="referenceLabel"><a href="#bib0130" class="label intra_ref">26</a></li><li class="author">S.H. Eshleman, D.R. Hoover, S. Chen, S.E. Hudelson, L.A. Guay, A. Mwatha, S.A. Fiscus, F. Mmiro, P. Musoke, J.B. Jackson <em>et al.</em></li><li class="title"><p>Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP</p></li><li class="source"><p>Journal of Infectious Diseases, 192 (2005), pp. 30–36</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref30" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref30'] = new Array();
        </script></li><li id="bib0135" data-t="r"><ul class="reference" id="bibsbref31"><li class="referenceLabel"><a href="#bib0135" class="label intra_ref">27</a></li><li class="author">R. Kantor</li><li class="title"><p>Impact of HIV-1 pol diversity on drug resistance and its clinical implications</p></li><li class="source"><p>Current Opinion in Infectious Diseases, 19 (2006), pp. 594–606</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref31" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref31'] = new Array();
        </script></li><li id="bib0140" data-t="r"><ul class="reference" id="bibsbref32"><li class="referenceLabel"><a href="#bib0140" class="label intra_ref">28</a></li><li class="author">J. Vingerhoets, H. Azijn, L. Tambuyzer, I. Dierynck, S. De Meyer, L. Rimsky, S. Nijs, G. De Smedt, M.P. de Bethune, G. Picchio</li><li class="title"><p>Short communication: activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data</p></li><li class="source"><p>AIDS Research and Human Retroviruses, 26 (2010), pp. 621–624</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref32" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref32'] = new Array();
        </script></li><li id="bib0145" data-t="r"><ul class="reference" id="bibsbref33"><li class="referenceLabel"><a href="#bib0145" class="label intra_ref">29</a></li><li class="author">A.I. Maiga, D. Descamps, L. Morand-Joubert, I. Malet, A. Derache, M. Cisse, V. Koita, A. Akonde, B. Diarra, M. Wirden <em>et al.</em></li><li class="title"><p>Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 54 (2010), pp. 728–733</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref33" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref33'] = new Array();
        </script></li><li id="bib0150" data-t="r"><ul class="reference" id="bibsbref34"><li class="referenceLabel"><a href="#bib0150" class="label intra_ref">30</a></li><li class="author">E.L. Asahchop, M. Oliveira, M.A. Wainberg, B.G. Brenner, D. Moisi, T. Toni, C.L. Tremblay</li><li class="title"><p>Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 55 (2011), pp. 600–607</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref34" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref34'] = new Array();
        </script></li><li id="bib0155" data-t="r"><ul class="reference" id="bibsbref35"><li class="referenceLabel"><a href="#bib0155" class="label intra_ref">31</a></li><li class="author">M.T. Lai, M. Lu, P.J. Felock, R.C. Hrin, Y.J. Wang, Y. Yan, S. Munshi, G.B. McGaughey, R.M. Tynebor, T.J. Tucker <em>et al.</em></li><li class="title"><p>Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 54 (2010), pp. 4812–4824</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref35" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref35'] = new Array();
        </script></li><li id="bib0160" data-t="r"><ul class="reference" id="bibsbref36"><li class="referenceLabel"><a href="#bib0160" class="label intra_ref">32</a></li><li class="author">A.L. McCormick, C.M. Parry, A. Crombe, R.L. Goodall, R.K. Gupta, P. Kaleebu, C. Kityo, M. Chirara, G.J. Towers, D. Pillay</li><li class="title"><p>Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 55 (2011), pp. 1806–1809</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref36" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref36'] = new Array();
        </script></li><li id="bib0165" data-t="r"><ul class="reference" id="bibsbref37"><li class="referenceLabel"><a href="#bib0165" class="label intra_ref">33•</a></li><li class="author">J.H. Brehm, D.L. Koontz, C.L. Wallis, K.A. Shutt, I. Sanne, R. Wood, J.A. McIntyre, W.S. Stevens, N. Sluis-Cremer, J.W. Mellors</li><li class="title"><p>Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors</p></li><li class="source"><p>Clinical Infectious Diseases, 55 (2012), pp. 737–745</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref37" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref37'] = new Array();
        </script><ul class="reference" id="bibsbref38"><li class="referenceLabel"><a href="#bib0165" class="label intra_ref">33•</a></li><li class="source"><p id="spar0035">N348I is a mutation in the connection domain of reverse transcriptase not normally covered by standard genotyping methods. Here it was found frequently in patients failing first-line NNRTI-based therapy and was associated with reduced susceptibility to etravirine.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref38" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref38'] = new Array();
        </script></li><li id="bib0170" data-t="r"><ul class="reference" id="bibsbref39"><li class="referenceLabel"><a href="#bib0170" class="label intra_ref">34</a></li><li class="author">C.J. Cohen, J.M. Molina, P. Cahn, B. Clotet, J. Fourie, B. Grinsztejn, H. Wu, M.A. Johnson, M. Saag, K. Supparatpinyo <em>et al.</em></li><li class="title"><p>Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials</p></li><li class="source"><p>Journal of Acquired Immune Deficiency Syndromes, 60 (2012), pp. 33–42</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref39" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref39'] = new Array();
        </script></li><li id="bib0175" data-t="r"><ul class="reference" id="bibsbref40"><li class="referenceLabel"><a href="#bib0175" class="label intra_ref">35</a></li><li class="author">L. Rimsky, J. Vingerhoets, V. Van Eygen, J. Eron, B. Clotet, A. Hoogstoel, K. Boven, G. Picchio</li><li class="title"><p>Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis</p></li><li class="source"><p>Journal of Acquired Immune Deficiency Syndromes, 59 (2012), pp. 39–46</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref40" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref40'] = new Array();
        </script></li><li id="bib0180" data-t="r"><ul class="reference" id="bibsbref41"><li class="referenceLabel"><a href="#bib0180" class="label intra_ref">36</a></li><li class="author">I. Lisovsky, S.M. Schader, J.L. Martinez-Cajas, M. Oliveira, D. Moisi, M.A. Wainberg</li><li class="title"><p>HIV-1 protease codon 36 polymorphisms and differential development of resistance to nelfinavir, lopinavir, and atazanavir in different HIV-1 subtypes</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 54 (2010), pp. 2878–2885</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref41" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref41'] = new Array();
        </script></li><li id="bib0185" data-t="r"><ul class="reference" id="bibsbref42"><li class="referenceLabel"><a href="#bib0185" class="label intra_ref">37</a></li><li class="author">J.L. Martinez-Cajas, M.A. Wainberg, M. Oliveira, E.L. Asahchop, F. Doualla-Bell, I. Lisovsky, D. Moisi, E. Mendelson, Z. Grossman, B.G. Brenner</li><li class="title"><p>The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors</p></li><li class="source"><p>Journal of Antimicrobial Chemotherapy, 67 (2012), pp. 988–994</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref42" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref42'] = new Array();
        </script></li><li id="bib0190" data-t="r"><ul class="reference" id="bibsbref43"><li class="referenceLabel"><a href="#bib0190" class="label intra_ref">38</a></li><li class="author">A.F. Santos, D.M. Tebit, M.S. Lalonde, A.B. Abecasis, A. Ratcliff, R.J. Camacho, R.S. Diaz, O. Herchenroder, M.A. Soares, E.J. Arts</li><li class="title"><p>Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 56 (2012), pp. 2719–2725</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref43" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref43'] = new Array();
        </script></li><li id="bib0195" data-t="r"><ul class="reference" id="bibsbref44"><li class="referenceLabel"><a href="#bib0195" class="label intra_ref">39</a></li><li class="author">L. Doyon, G. Croteau, D. Thibeault, F. Poulin, L. Pilote, D. Lamarre</li><li class="title"><p>Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors</p></li><li class="source"><p>Journal of Virology, 70 (1996), pp. 3763–3769</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref44" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref44'] = new Array();
        </script></li><li id="bib0200" data-t="r"><ul class="reference" id="bibsbref45"><li class="referenceLabel"><a href="#bib0200" class="label intra_ref">40</a></li><li class="author">C.M. Parry, M. Kolli, R.E. Myers, P.A. Cane, C. Schiffer, D. Pillay</li><li class="title"><p>Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity</p></li><li class="source"><p>Antimicrobial Agents and Chemotherapy, 55 (2011), pp. 1106–1113</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref45" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref45'] = new Array();
        </script></li><li id="bib0205" data-t="r"><ul class="reference" id="bibsbref46"><li class="referenceLabel"><a href="#bib0205" class="label intra_ref">41</a></li><li class="author">J. Ghosn, C. Delaugerre, P. Flandre, J. Galimand, I. Cohen-Codar, F. Raffi, J.F. Delfraissy, C. Rouzioux, M.L. Chaix</li><li class="title"><p>Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen</p></li><li class="source"><p>PLoS ONE, 6 (2011), p. e24798</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref46" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref46'] = new Array();
        </script></li><li id="bib0210" data-t="r"><ul class="reference" id="bibsbref47"><li class="referenceLabel"><a href="#bib0210" class="label intra_ref">42</a></li><li class="author">J.A. Bartlett, H.J. Ribaudo, C.L. Wallis, E. Aga, D.A. Katzenstein, W.S. Stevens, M.R. Norton, K.L. Klingman, M.C. Hosseinipour, J.A. Crump <em>et al.</em></li><li class="title"><p>Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings</p></li><li class="source"><p>AIDS, 26 (2012), pp. 1345–1354</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref47" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref47'] = new Array();
        </script></li><li id="bib0215" data-t="r"><ul class="reference" id="bibsbref48"><li class="referenceLabel"><a href="#bib0215" class="label intra_ref">43</a></li><li class="author">J.K. Rockstroh, H. Teppler, J. Zhao, P. Sklar, M.D. Miller, C.M. Harvey, K.M. Strohmaier, R.Y. Leavitt, B.Y. Nguyen</li><li class="title"><p>Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies</p></li><li class="source"><p>AIDS, 25 (2011), pp. 1365–1369</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref48" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref48'] = new Array();
        </script></li><li id="bib0220" data-t="r"><ul class="reference" id="bibsbref49"><li class="referenceLabel"><a href="#bib0220" class="label intra_ref">44</a></li><li class="author">M.Q. Fish, R. Hewer, C.L. Wallis, W.D. Venter, W.S. Stevens, M.A. Papathanasopoulos</li><li class="title"><p>Natural polymorphisms of integrase among HIV type 1-infected South African patients</p></li><li class="source"><p>AIDS Research and Human Retroviruses, 26 (2010), pp. 489–493</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref49" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref49'] = new Array();
        </script></li><li id="bib0225" data-t="r"><ul class="reference" id="bibsbref50"><li class="referenceLabel"><a href="#bib0225" class="label intra_ref">45</a></li><li class="author">C. Garrido, A.M. Geretti, N. Zahonero, C. Booth, A. Strang, V. Soriano, C. De Mendoza</li><li class="title"><p>Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection</p></li><li class="source"><p>Journal of Antimicrobial Chemotherapy, 65 (2010), pp. 320–326</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref50" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref50'] = new Array();
        </script></li><li id="bib0230" data-t="r"><ul class="reference" id="bibsbref51"><li class="referenceLabel"><a href="#bib0230" class="label intra_ref">46</a></li><li class="author">S. Sierra, N. Lubke, H. Walter, E. Schulter, S. Reuter, G. Fatkenheuer, M. Bickel, H. da Silva, R. Kaiser, S. Esser</li><li class="title"><p>The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes</p></li><li class="source"><p>Medical Microbiology and Immunology, 200 (2011), pp. 225–232</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref51" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref51'] = new Array();
        </script></li><li id="bib0235" data-t="r"><ul class="reference" id="bibsbref52"><li class="referenceLabel"><a href="#bib0235" class="label intra_ref">47</a></li><li class="author">T. Bar-Magen, D.A. Donahue, E.I. McDonough, B.D. Kuhl, V.H. Faltenbacher, H. Xu, V. Michaud, R.D. Sloan, M.A. Wainberg</li><li class="title"><p>HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays</p></li><li class="source"><p>AIDS, 24 (2010), pp. 2171–2179</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref52" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref52'] = new Array();
        </script></li><li id="bib0240" data-t="r"><ul class="reference" id="bibsbref53"><li class="referenceLabel"><a href="#bib0240" class="label intra_ref">48</a></li><li class="author">C. Garrido, V. Soriano, A.M. Geretti, N. Zahonero, S. Garcia, C. Booth, F. Gutierrez, I. Viciana, C. de Mendoza</li><li class="title"><p>Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients – impact of HIV subtypes and prior raltegravir experience</p></li><li class="source"><p>Antiviral Research, 90 (2011), pp. 164–167</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref53" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref53'] = new Array();
        </script></li><li id="bib0245" data-t="r"><ul class="reference" id="bibsbref54"><li class="referenceLabel"><a href="#bib0245" class="label intra_ref">49•</a></li><li class="author">P.K. Quashie, T. Mesplede, Y.S. Han, M. Oliveira, D.N. Singhroy, T. Fujiwara, M.R. Underwood, M.A. Wainberg</li><li class="title"><p>Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir</p></li><li class="source"><p>Journal of Virology, 86 (2012), pp. 2696–2705</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref54" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref54'] = new Array();
        </script><ul class="reference" id="bibsbref55"><li class="referenceLabel"><a href="#bib0245" class="label intra_ref">49•</a></li><li class="source"><p id="spar0040">This study suggests that the next-generation integrase inhibitor dolutegravir might have different resistance pathways in subtype B and C.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref55" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref55'] = new Array();
        </script></li><li id="bib0250" data-t="r"><ul class="reference" id="bibsbref56"><li class="referenceLabel"><a href="#bib0250" class="label intra_ref">50</a></li><li class="author">T. Bar-Magen, R.D. Sloan, D.A. Donahue, B.D. Kuhl, A. Zabeida, H. Xu, M. Oliveira, D.J. Hazuda, M.A. Wainberg</li><li class="title"><p>Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor</p></li><li class="source"><p>Journal of Virology, 84 (2010), pp. 9210–9216</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref56" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref56'] = new Array();
        </script></li><li id="bib0255" data-t="r"><ul class="reference" id="bibsbref57"><li class="referenceLabel"><a href="#bib0255" class="label intra_ref">51</a></li><li class="author">A.M. Geretti, L. Harrison, H. Green, C. Sabin, T. Hill, E. Fearnhill, D. Pillay, D. Dunn</li><li class="title"><p>Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy</p></li><li class="source"><p>Clinical Infectious Diseases, 48 (2009), pp. 1296–1305</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref57" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref57'] = new Array();
        </script></li><li id="bib0260" data-t="r"><ul class="reference" id="bibsbref58"><li class="referenceLabel"><a href="#bib0260" class="label intra_ref">52•</a></li><li class="author">A.U. Scherrer, B. Ledergerber, V. von Wyl, J. Boni, S. Yerly, T. Klimkait, P. Burgisser, A. Rauch, B. Hirschel, M. Cavassini <em>et al.</em></li><li class="title"><p>Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B</p></li><li class="source"><p>Clinical Infectious Diseases, 53 (2011), pp. 1143–1152</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref58" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref58'] = new Array();
        </script><ul class="reference" id="bibsbref59"><li class="referenceLabel"><a href="#bib0260" class="label intra_ref">52•</a></li><li class="source"><p id="spar0045">This large cohort study was able to demonstrate that virological outcomes in non-B subtypes are at least as good as, if not better than, subtype B.</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref59" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref59'] = new Array();
        </script></li><li id="bib0265" data-t="r"><ul class="reference" id="bibsbref60"><li class="referenceLabel"><a href="#bib0265" class="label intra_ref">53</a></li><li class="author">I. Dierynck, S. De Meyer, E. Lathouwers, C. Vanden Abeele, T. Van De Casteele, S. Spinosa-Guzman, M.P. de Bethune, G. Picchio</li><li class="title"><p>In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients</p></li><li class="source"><p>Antiviral Therapy, 15 (2010), pp. 1161–1169</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref60" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref60'] = new Array();
        </script></li><li id="bib0270" data-t="r"><ul class="reference" id="bibsbref61"><li class="referenceLabel"><a href="#bib0270" class="label intra_ref">54</a></li><li class="author">D.A. Cooper, J. Heera, J. Goodrich, M. Tawadrous, M. Saag, E. Dejesus, N. Clumeck, S. Walmsley, N. Ting, E. Coakley <em>et al.</em></li><li class="title"><p>Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection</p></li><li class="source"><p>Journal of Infectious Diseases, 201 (2010), pp. 803–813</p></li><li data-sr="N" class="external refPlaceHolder" id="bibsbref61" data-refres="N"> <span style="color: red;"> [SD-008]</span></li></ul><script language="Javascript" type="text/javascript">

             myMap['bibsbref61'] = new Array();
        </script></li></ol><div class="artFooterContent"><!--footerNotes--></div><!--VALIDHTML--><p class="copyright">Copyright © 2012 Elsevier B.V. Published by Elsevier B.V. All rights reserved.</p><!--VALIDHTML-->
<script>prs.rt('data_end');</script>
       
        
    <div style="height: 0px;" id="pStretcher"></div></div>
 </div>
 <div style="top: 26px; overflow: hidden; left: 961px; width: 640px;" id="rightPane" class="column js" aria-label="Related content" role="complementary">
   <div style="display: none;" class="toggleSideBar">
      <a tabindex="0">
         <div class="close" title="Open to view article outline"></div>
      </a>
    </div>
    <iframe class="dummyiFrame" border="0" style="position: absolute; background: none repeat ; 0% transparent; border: 0px none; top: 0px; left: 0px; width: 100%; height: 100%; z-index: -1;" src="S1879625712001320_1.html" frameborder="0"></iframe>
    <div style="margin-left: 0px; width: 638px;" role="tablist" id="rightInner" class="rightInner js ui-accordion ui-widget ui-helper-reset">
       <h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-0" id="ui-accordion-rightInner-header-0" role="tab" class="accordionHead first-tab bibliographic ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Bibliographic information
</h2>
<div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-0" id="ui-accordion-rightInner-panel-0" style="display: none; height: 139px; overflow: auto; background-color: rgb(236, 242, 246);" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="width: 605px;" class="innerPadding js_bibliographic_content">

    </div>
</div>


  <h2 tabindex="0" aria-selected="true" aria-controls="ui-accordion-rightInner-panel-1" id="ui-accordion-rightInner-header-1" role="tab" class="accordionHead relatedArticles ui-accordion-header ui-helper-reset ui-state-default ui-accordion-header-active ui-state-active ui-corner-top">
    <span class="showHideIcon"></span>
    Citing and related articles
  </h2>
  <div aria-hidden="false" aria-expanded="true" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-1" id="ui-accordion-rightInner-panel-1" style="display: block; height: 139px; background-color: rgb(236, 242, 246); overflow: auto;" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom ui-accordion-content-active">
    <div style="width: 605px;" class="innerPadding js_citation_content">
      
        
     

     
        <div class="articleList">
            <ol id="specIssueList"></ol>
        </div>        
    
     
        <div class="articleList">
             <h3>Related articles</h3>
             <ol id="relArtList"><li class="note"><p>No articles found.</p></li></ol>
        </div>
     

     
         
             <ol class="citedByLink"><div class="boxLink"><a href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science?_ob=RedirectURL&amp;_method=outwardLink&amp;_partnerName=656&amp;_eid=1-s2.0-S1879625712001320&amp;_pii=S1879625712001320&amp;_origin=article&amp;_zone=art_page&amp;_targetURL=http%3A%2F%2Fwww.scopus.com%2Finward%2Fcitedby.url%3Feid%3D2-s2.0-84867397003%26partnerID%3D10%26rel%3DR3.0.0%26md5%3D36091fec559290bf2f8581b4299ea3cf&amp;_acct=C000007922&amp;_version=1&amp;_userid=103680&amp;md5=4272df634c10f1f43f6b032ff9ceb174" rel="nofollow" class="olSpawnWindow" target="outwardLink"></a> <font color="#000000"> <span class="scopus_logo_txt">Cited by in Scopus (0)</span></font></div></ol>
         
     

     
         
             <div class="articleList">
                 <h3>Related reference work articles</h3>
                 <ol id="relRefList"><li class="note"><p>No articles found.</p></li></ol>
             </div>
         
      

    </div>
  </div>



  <h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-2" id="ui-accordion-rightInner-header-2" role="tab" class="accordionHead applications ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Applications and tools
  </h2>
  <div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-2" id="ui-accordion-rightInner-panel-2" style="height: 139px; overflow: auto; visibility: hidden; top: -1000px; position: absolute; left: -1000px;" class="accordionContent ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="width: 625px;" class="innerPaddingApp js_application_content">

      
        <div id="SD_AT1P" class="boxLink sgfNoTitleBar sgfNoGadgetBorder"></div>
      

      
        <div id="SD_FTA1" class="boxLink sgfHorToolbar sgfShowMyApps sgfShowMoreLessApps"></div>
      

    </div>
  </div>


<h2 tabindex="-1" aria-selected="false" aria-controls="ui-accordion-rightInner-panel-3" id="ui-accordion-rightInner-header-3" role="tab" class="accordionHead last-tab workspace ui-accordion-header ui-helper-reset ui-state-default ui-corner-all">
    <span class="showHideIcon"></span>
    Workspace
</h2>
<div aria-hidden="true" aria-expanded="false" role="tabpanel" aria-labelledby="ui-accordion-rightInner-header-3" id="ui-accordion-rightInner-panel-3" style="display: none; height: 139px; overflow: auto;" class="accordionContent ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom">
    <div style="" class="innerPadding js_workspace_content">
        <div style="width: 600px;" class="scrollArea">
           <li class="note"><p>No content has been selected.</p></li>
           <div id="workSpaceView"></div>
        </div>
    </div>
    <div class="hidescrollbar"></div>
</div>

    </div>
 </div>
</div>
<div style="clear: both;"></div>
<div style="width: 1606px; left: 62px; height: 0px; display: none;" class="js" id="footer-area" aria-label="product support" role="contentinfo">
  <div id="sdFoot">
    <div id="footer">	
  <div class="bottomArticle"></div>
  <div class="padding">
    <div id="linkArea">
      <div class="padding">
        <div style="float: left; width: 0px; height: 1px;"></div>
        <div id="banner-bottom">
          <a href="http://www.elsevier.com.libgate.library.nuigalway.ie/" target="_top"><img src="wordmark_elsevier.png" alt="Elsevier homepage (opens in a new window)" title="Elsevier homepage (opens in a new window)"></a>
        </div>
        <ul class="col5">
<li><a target="_top" href="http://www.info.sciverse.com/sciencedirect?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=aboutsd">About ScienceDirect</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=aboutelsevier">About Elsevier</a></li>
</ul>
<ul class="col5">
<li> <a target="_top" href="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/contactus">Contact and support</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevierscitech.com/forms/sd/form.html?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=advert">Information for advertisers</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/locate/termsandconditions?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=terms">Terms and conditions</a></li>
</ul>
<ul class="col5">
<li><a target="_top" href="http://www.elsevier.com.libgate.library.nuigalway.ie/privacypolicy?utm_source=sciencedirect&amp;utm_medium=link&amp;utm_campaign=privacy">Privacy policy</a></li>
</ul>
<script>function loadSCode(){if(typeof SDM!="undefined"){var e=document.getElementsByTagName("body")[0],t=document.createElement("script");t.src="//cdn.els-cdn.com/sd/js/adobe/s_code_131.js";e.appendChild(t);sendSCStats()}else{setTimeout(loadSCode,100)}}function sendSCStats(){if(typeof s_tc_sciencedirect!="undefined"){s.t()}else{setTimeout(sendSCStats,100)}}if(window.addEventListener){window.addEventListener("load",loadSCode,false)}else if(window.attachEvent){window.attachEvent("onload",loadSCode)}else{window.onload=loadSCode}</script>
        <div class="clear"></div>
        <!-- CSAS will be providing the links-->
      </div>
      <div class="padding" style="padding-top: 8px; padding-bottom: 4px; font-size: 11px;">

        Copyright © 2013 <a href="http://www.elsevier.com.libgate.library.nuigalway.ie/" target="_top">Elsevier B.V.</a> All rights reserved.  SciVerse® is a registered trademark of Elsevier Properties S.A., used under license. ScienceDirect® is a registered trademark of Elsevier B.V.
      </div>
      <div class="padding" style="padding-bottom: 4px; padding-top: 0px; font-size: 11px;">

              Cookies are used by this site. To decline or learn more, visit our <a href="http://www.info.sciverse.com/sciencedirect/cookies" target="_top">Cookies</a> page
        </div> 
    </div>
  </div>
</div> <!--footer-->

  </div><!--sdFooter-->
</div><!--footer-area-->


<form name="citationInfo" id="citationInfo" method="POST" action="http://www.sciencedirect.com.libgate.library.nuigalway.ie/science/article/pii/S1879625712001320?np=y">
    <input name="art_citation" value="" type="hidden">
</form>
<div id="pdfModalWindow" class="pdfModalWindow" style="display: none;" onclick="pdfCite.closePopup();"></div>


<!-- PDFKING/PDFCITE -->
<div id="suggestedPdfList" style="display: none;">

</div>


<script src="sdX_131R4.js"></script>
<script src="sd_131R4.js"></script>
<script>

var sciverse="empty";
var SDM=new Object;
SDM.tm=new Object;
SDM.tm.ahm='h'
SDM.tm.chm='h'


SDM.pm=new Object;
SDM.pm.contentType = 'JL';
SDM.doi = '10.1016/j.coviro.2012.08.006';
SDM.pm.issn_or_isbn = "18796257";
SDM.pm.mod_ISBN = "";
  SDM.isMRWMODArticle = false ; 
 
SDM.pm.mod_cid="";
SDM.pm.mod_srcTitle="";
SDM.pm.pii = 'S1879625712001320';
SDM.pm.cid = '270558';
SDM.pm.eid = '1-s2.0-S1879625712001320';
SDM.pm.pdfEid = '1-s2.0-S1879625712001320-main.pdf';
SDM.pm.pdfSize = '434483';
SDM.pm.coverDate = '2012-Oct-31';
SDM.pm.itemWeight = 'FULL-TEXT';
SDM.pm.indexType = '';





SDM.pf = new Object;
SDM.pf.dc = new Object;
SDM.pf.dc.retry = 10;
SDM.pf.dc.retryDelay = 300;
SDM.pf.dc.retryFactor = 1.0;

SDM.pf.er = new Object;

SDM.pf.er.epub = new Object;
SDM.pf.er.epub.name = 'ePub';
SDM.pf.er.epub.retry = 5;
SDM.pf.er.epub.retryDelay = 2000;
SDM.pf.er.epub.retryFactor = 1.0;
SDM.pf.er.epub.msgDelay = 1500;
SDM.pf.er.epub.msgType = 'rect';
SDM.pf.er.epub.msgImg = 'epubAnim.gif';
SDM.pf.er.epub.url='http://www.sciencedirect.com/science/ereader/epub/S1879625712001320/1369128829/18796257/1-s2.0-S1879625712001320/serial/?md5=2c1115c5b9bfc4b7408f51c45e180a82';


SDM.pf.er.mobi = new Object;
SDM.pf.er.mobi.name = 'Mobipocket';
SDM.pf.er.mobi.retry = 5;
SDM.pf.er.mobi.retryDelay = 2000;
SDM.pf.er.mobi.retryFactor = 1.0;
SDM.pf.er.mobi.msgDelay = 1500;
SDM.pf.er.mobi.msgType = 'rect';
SDM.pf.er.mobi.msgImg = 'mobiAnim.gif';
SDM.pf.er.mobi.url='http://www.sciencedirect.com/science/ereader/mobi/S1879625712001320/1369128829/18796257/1-s2.0-S1879625712001320/serial/?md5=2c1115c5b9bfc4b7408f51c45e180a82';






SDM.pm.toc=new Object;
SDM.pm.toc.retry = 20;
SDM.pm.toc.retryDelay = 1000;
SDM.pm.toc.retryFactor = 1.09;
 SDM.tocJson = '{"PII":"S1879625712001320","EID":"1-s2.0-S1879625712001320","TIMESTAMP":"2012-10-12T13:16:04.757415-04:00","TOC":[{"dummy": "dummy"}, {"sT":"", "sID":"section_abstract", "cT":[ {"sT":"", "sID":"absSec_1" } ] }, {"sT":"", "sID":"section_gabs", "faID":[  ] , "cT":[ {"sT":"Highlights", "sID":"secGabs_1" } ] }, {"sT":"Introduction", "sID":"sec0005", "faID":[ {"dummy": "dummy"} ] },{"sT":"HIV-1 origin, subtypes and recombinants", "sID":"sec0010", "faID":[ {"dummy": "dummy"} ] },{"sT":"Subtyping tools and drug resistance databases", "sID":"sec0015", "faID":[ {"dummy": "dummy"}, {"fID":"fig0005", "fT":"fig","fL":"Figure 1", "fI":"gr1.sml","fIh":"164"},{"fID":"tbl0005", "fT":"tbl","fL":"Table 1"} ] },{"sT":"Nucleoside and nucleotide reverse transcriptase inhibitors", "sID":"sec0020", "faID":[ {"dummy": "dummy"} ] },{"sT":"Non-nucleoside reverse transcriptase inhibitors", "sID":"sec0025", "faID":[ {"dummy": "dummy"} ] },{"sT":"Protease inhibitors", "sID":"sec0030", "faID":[ {"dummy": "dummy"} ] },{"sT":"Integrase inhibitors", "sID":"sec0035", "faID":[ {"dummy": "dummy"} ] },{"sT":"Clinical efficacy of new antiretroviral agents by HIV-1 subtype", "sID":"sec0040", "faID":[ {"dummy": "dummy"},{"fID":"tbl0010", "fT":"tbl","fL":"Table 2"} ] },{"sT":"Conclusions", "sID":"sec0045", "faID":[ {"dummy": "dummy"} ] },{"sT":"References and recommended reading", "sID":"sec0050", "faID":[ {"dummy": "dummy"} ] }, {"sT":"Acknowledgements", "sID":"ack001"} , {"sT":"References", "sID":"bibl00bibl0005"} ]}';
 SDM.tocCacheAvail=true; 


SDM.ep=new Object;
SDM.ep.imgBase = "http://cdn.els-cdn.com/sd";
SDM.ep.urlPrefix = "http://www.sciencedirect.com/science";
SDM.ep.refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S1879625712001320";
SDM.ep.updatedCitedBy = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_updateCitedBy=";
SDM.ep.refResolvePath = "http://www.sciencedirect.com/science/referenceResolution/ajaxRefResol?_eid=1-s2.0-S1879625712001320&_refCnt=61&_docType=article";
SDM.breadCrumbPathURL = "http://www.sciencedirect.com/science/module/breadCrumbPaths/isbn//pii/S1879625712001320";

SDM.ldrAvail = true;
SDM.ep.crossMarkURL = "http://www.sciencedirect.com/science/crossMark";
SDM.ep.crossMarkLib = "http://crossmark.crossref.org/javascripts/crossmark.min.js";
SDM.ep.userActionURL = "http://www.sciencedirect.com/science/UserActions"
SDM.ep.svShindigLib="http://sciverse-shindig.elsevier.com/gadgets/js/shindig-container:pubsub-2.js?c=1";
SDM.ep.svSciverseLib="http://www.sciencedirect.com/gadgetservices/gadgets/v3_1/js/SciverseShindigService,GadgetToolBar,jquery-outside,jquery.ba-bbq.min,SciverseShindigContainer,ScienceDirectShindigServices.js";
SDM.ep.downloadCsvURL = "http://services.elsevier.com/SDWebExport/export/table/csv";
SDM.ep.downloadActionURL = "http://www.sciencedirect.com/science/downloadActions/keyEvent/S1879625712001320/18796257";
SDM.ep.gigyaLib="//cdn.gigya.com/JS/socialize.js?apiKey=3__Bt7bHrGM8mjKPwBuOVjWyMi678aF6-PewcnoHJJ6UR1fS5t9NG9RBbKHjE0oA6J";

SDM.urlPrefix = "http://www.sciencedirect.com/science";
SDM.refLinkURL = "http://www.sciencedirect.com/science/relLink/ajaxReq?_eid=1-s2.0-S1879625712001320";

SDM.imageUrlPrefix = "http://ars.els-cdn.com/content/image/";
SDM.staticImageUrlPrefix = "http://cdn.els-cdn.com/sd";

SDM.prodColor="sci_dir";if(SDM.prodColor=="sci_dir")SDM.prodColor="";

SDM.pageTransKey = "05/21/2013 05:33:49 EDT#1847_005#110524#140.203.12.206";
SDM.pageType = "article_full";

  SDM.webUserId = "103680";
  SDM.contentType = "JL";
  SDM.issn_or_isbn = "18796257";
  SDM.sds = "2e18eee40c89053dc2638674c1d41bbc3e64c57dff46926614ecfec2c189dc0cfa53a596634aeb842a6fc07bba595dc6";
  SDM.tid = "8ac170bc-c1f9-11e2-8542-00000aab0f26";
  SDM.ud = "103680|<SAInfo><SAId>17</SAId><SAName>IRELAND University Consortium</SAName><SANum>S000000017</SANum></SAInfo>|C000007922|14110|IPRANGE";
  SDM.pru = "http://pa.elsevier.com";
  SDM.crossMarkURL = "http://www.sciencedirect.com/science/crossMark";
  SDM.crossMarkLib = "http://crossmark.crossref.org/javascripts/crossmark.min.js";
 SDM.isCrossMark=false; 
  SDM.keOriginContentFamily = "serial"
  SDM.userActionURL = "http://www.sciencedirect.com/science/UserActions"
  SDM.sciverseUrlPfx="http://www.sciencedirect.com";
  SDM.sciverseJsonObject='';
  SDM.sciverseGadgetDetailsID = "c92301a3-a259-4baf-b22f-a9474d079495";
SDM.fullSize = true;
SDM.outlineGraphics = true;
SDM.outlineTab = "";
SDM.outlineImgFence = true;
SDM.entitled = true;
SDM.urlTOCLink="http://www.sciencedirect.com/science/article/pii/S1879625712001320";
SDM.urlTOCLinkQueryStr="?_rdoc=1&_fmt=full&_origin=&md5=22543fb95e34d36391c44b9d9cd72533";

SDM.displayGadgets=true;
SDM.euidCookieObject='095fd086970485e8ace6ce92291eca0681fab96fd0ac013d658f5c90fea3a19a451f6e80d7dff275';

SDM.adArticleOptionsURL="/science/advertisement/options/num/574991/mainCat/general/cat/general/acct/caf12c083b5a42c1c4723593daa096bf/isn/18796257/doi/10.1016_j.coviro.2012.08.006/page/article";
SDM.adArticleRightSmURL="";
SDM.adArticleRightLgURL="";
SDM.adReqOutline=false;
SDM.adReqOptions=false;
SDM.relatedRefAvail=true;
SDM.mlktAvail = true;
SDM.citedByScAvail = false;
SDM.crawlerAvail = false;
SDM.outwardLinks = '<div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=19979&_eid=1-s2.0-S1879625712001320&_pii=S1879625712001320&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1879625712001320%3Fshowall%3Dtrue&_acct=C000007922&_version=1&_userid=103680&md5=80468d35094a8f4a0e68b8399e0f4dae"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://www.sciencedirect.com.libgate.library.nuigalway.ie/scidirimg/gw_rtn_ihub.gif" alt="Get Full Text Elsewhere" title="Get Full Text Elsewhere" border="0"></a></div></div><div class="tableFmDivider">&nbsp;</div><div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=254&_eid=1-s2.0-S1879625712001320&_pii=S1879625712001320&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Fsfxhosted.exlibrisgroup.com%2Fgalway%3Fctx_ver%3DZ39.88-2004%26ctx_enc%3Dinfo%3Aofi%2Fenc%3AUTF-8%26url_ver%3DZ39.88-2004%26rfr_id%3Dinfo%3Asid%2FElsevier%3ASD%26svc_val_fmt%3Dinfo%3Aofi%2Ffmt%3Akev%3Amtx%3Asch_svc%26rft_val_fmt%3Dinfo%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal%26rft.aulast%3DLESSELLS%26rft.auinit%3DR%26rft.date%3D2012%26rft.issn%3D18796257%26rft.volume%3D2%26rft.issue%3D5%26rft.spage%3D636%26rft.epage%3D643%26rft.title%3DCurrent%2520Opinion%2520in%2520Virology%26rft.atitle%3DAre%2520subtype%2520differences%2520important%2520in%2520HIV%2520drug%2520resistance%253F%26rft_id%3Dinfo%3Adoi%2F10.1016%2Fj.coviro.2012.08.006&_acct=C000007922&_version=1&_userid=103680&md5=fb24dbadc26cbdbf11bf97b941070e2a"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://sfxhosted.exlibrisgroup.com.libgate.library.nuigalway.ie/galway/sfx.gif" alt="More related information in NUI, Galway" title="More related information in NUI, Galway" border="0"></a></div></div><div class="tableFmDivider">&nbsp;</div><div class="olLeftMiddle"><div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=5978&_eid=1-s2.0-S1879625712001320&_pii=S1879625712001320&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Flinkinghub.pangaea.de%2Felsevier%2FredirectToSupplement%2F10.1016%2Fj.coviro.2012.08.006&_acct=C000007922&_version=1&_userid=103680&md5=a0f0b87a2041e8badd07d128bc2e37e1"  rel="nofollow" class="olSpawnWindow" target="outwardLink"><img src="http://linkinghub.pangaea.de/elsevier/supplementBanner/10.1016/j.coviro.2012.08.006" alt="PANGAEA Supplementary Data" title="PANGAEA Supplementary Data" border="0"></a></div></div><div class="olLeftMiddle"><div class="boxLink SC_record"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=655&_eid=1-s2.0-S1879625712001320&_pii=S1879625712001320&_origin=article&_zone=rightPane&_targetURL=http%3A%2F%2Fwww.scopus.com%2Finward%2Frecord.url%3Feid%3D2-s2.0-84867397003%26partnerID%3D10%26rel%3DR3.0.0%26md5%3D36091fec559290bf2f8581b4299ea3cf&_acct=C000007922&_version=1&_userid=103680&md5=c77df074b49d3f4207b2fac7f03b07de"  rel="nofollow" class="olSpawnWindow" target="outwardLink">View Record in Scopus</a></div></div>';
   SDM.doi = '10.1016/j.coviro.2012.08.006'; 
 SDM.isSpecialIssue=true; 
 SDM.hubEid = '1-s2.0-S1879625712X00063'; 


 SDM.relatedCitingPanelAvail = true; 
 SDM.applicationsPanelAvail=true; 
 SDM.rerunJson =''; 
 SDM.rerunAvail=true; 
 SDM.helpUrlDomain = "#";
 SDM.permAndReprint='<div class="boxLink"><a href="/science?_ob=RedirectURL&_method=outwardLink&_partnerName=936&_eid=1-s2.0-S1879625712001320&_pii=S1879625712001320&_origin=article&_zone=art_page&_targetURL=https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3FpublisherName%3DELS%26contentID%3DS1879625712001320%26orderBeanReset%3Dtrue&_acct=C000007922&_version=1&_userid=103680&md5=2aeecd4e1615edc7b5e50df625ea7df9"  rel="nofollow" class="olSpawnWindow" target="outwardLink">Permissions & Reprints</a></div>'; 
 SDM.ppvMsg=''; 

SDM.ignoreForceAbst=false;
 
SDM.blk_all_social_logins='Y';

var googleAds = '';

SDM.svapi = SVApi;

</script>


<script>


initializeArticlePage();
</script>












<script>

  prs.rt('body_end');
  
</script>


<ul style="z-index: 62; display: none;" tabindex="0" id="ui-id-1" class="ui-autocomplete ui-menu ui-widget ui-widget-content ui-corner-all"></ul><script src="s_code_131.js"></script><img style="display: none;" src="pageReport"></body>
</html>
